BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020;127:104370. [PMID: 32344321 DOI: 10.1016/j.jcv.2020.104370] [Cited by in Crossref: 291] [Cited by in F6Publishing: 284] [Article Influence: 145.5] [Reference Citation Analysis]
Number Citing Articles
1 Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight? Med Hypotheses 2020;144:110231. [PMID: 33254538 DOI: 10.1016/j.mehy.2020.110231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
2 Dima A, Balaban DV, Jurcut C, Berza I, Jurcut R, Jinga M. Physicians' Perspectives on COVID-19: An International Survey. Healthcare (Basel) 2020;8:E250. [PMID: 32748880 DOI: 10.3390/healthcare8030250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bhandari M, Pradhan A, Vishwakarma P, Sethi R. Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol 2021; 13(10): 556-565 [PMID: 34754400 DOI: 10.4330/wjc.v13.i10.556] [Reference Citation Analysis]
4 Dai J, Xiong Y, Li H, Qian Y, Xu Y, Xu Q, Yan X, Tang J. Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review. Clin Rheumatol 2020;39:2031-7. [PMID: 32451729 DOI: 10.1007/s10067-020-05172-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP). Viruses 2022;14:481. [DOI: 10.3390/v14030481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Khan M, Shah N, Mushtaq H, Jehanzeb V. Profiling Laboratory Biomarkers Associated with COVID-19 Disease Progression: A Single-Center Experience. Int J Microbiol 2021;2021:6643333. [PMID: 33628256 DOI: 10.1155/2021/6643333] [Reference Citation Analysis]
7 Kurushina OV, Barulin AE. [Effects of COVID-19 on the central nervous system]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:92-7. [PMID: 33580768 DOI: 10.17116/jnevro202112101192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sandor-Keri J, Benedek I, Polexa S, Benedek I. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality. J Clin Med 2021;10:3015. [PMID: 34300181 DOI: 10.3390/jcm10143015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon 2020;6:e05684. [PMID: 33344791 DOI: 10.1016/j.heliyon.2020.e05684] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
10 Boezaart AP, Botha DA. Treatment of Stage 3 COVID-19 With Transcutaneous Auricular Vagus Nerve Stimulation Drastically Reduces Interleukin-6 Blood Levels: A Report on Two Cases. Neuromodulation 2021;24:166-7. [PMID: 33063409 DOI: 10.1111/ner.13293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Simon TP, Stoppe C, Breuer T, Stiehler L, Dreher M, Kersten A, Kluge S, Karakas M, Zechendorf E, Marx G, Martin L. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study. J Clin Med 2021;10:1667. [PMID: 33924637 DOI: 10.3390/jcm10081667] [Reference Citation Analysis]
12 Gao F, Zheng KI, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, Targher G, Byrne CD, George J, Zheng MH. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front Endocrinol (Lausanne) 2021;12:604100. [PMID: 33763027 DOI: 10.3389/fendo.2021.604100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Keddie S, Ziff O, Chou MKL, Taylor RL, Heslegrave A, Garr E, Lakdawala N, Church A, Ludwig D, Manson J, Scully M, Nastouli E, Chapman MD, Hart M, Lunn MP. Laboratory biomarkers associated with COVID-19 severity and management. Clin Immunol 2020;221:108614. [PMID: 33153974 DOI: 10.1016/j.clim.2020.108614] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
14 Beydoğan E, Yürük Atasoy P. The relationship between CRP at admission and thorax CT findings in patients diagnosed with COVID-19. Int J Clin Pract 2021;:e14962. [PMID: 34624163 DOI: 10.1111/ijcp.14962] [Reference Citation Analysis]
15 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, Pablo España P, Quintana JM, García-Gutiérrez S; el grupo de trabajo COVID-19-Osakidetza. [Risk factors for clinical deterioration in patients admitted for COVID-19: a case-control study]. Rev Clin Esp 2021. [PMID: 34054133 DOI: 10.1016/j.rce.2021.04.007] [Reference Citation Analysis]
16 Israni A, Goulden CJ, Harky A. Laboratory biomarkers and prognosis in Covid-19, where do we stand? Rev Med Virol 2021;31:e2296. [PMID: 34516018 DOI: 10.1002/rmv.2296] [Reference Citation Analysis]
17 Mitsumura T, Okamoto T, Shirai T, Iijima Y, Sakakibara R, Honda T, Ishizuka M, Aiboshi J, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Predictors associated with clinical improvement of SARS-CoV-2 pneumonia. J Infect Chemother 2021;27:857-63. [PMID: 33676842 DOI: 10.1016/j.jiac.2021.02.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ileri C, Dogan Z, Ozben B, Karaoglu C, Gunay N, Tigen K, Basat S, Uyan C. Evaluation of the relation between cardiac biomarkers and thorax computed tomography findings in COVID-19 patients. Biomark Med 2021;15:285-93. [PMID: 33501850 DOI: 10.2217/bmm-2020-0388] [Reference Citation Analysis]
19 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
20 Jackson BR, Gold JAW, Natarajan P, Rossow J, Neblett Fanfair R, da Silva J, Wong KK, Browning SD, Bamrah Morris S, Rogers-Brown J, Hernandez-Romieu AC, Szablewski CM, Oosmanally N, Tobin-D'Angelo M, Drenzek C, Murphy DJ, Hollberg J, Blum JM, Jansen R, Wright DW, SeweSll WM, Owens JD, Lefkove B, Brown FW, Burton DC, Uyeki TM, Bialek SR, Patel PR, Bruce BB. Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19. Clin Infect Dis 2020:ciaa1459. [PMID: 32971532 DOI: 10.1093/cid/ciaa1459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
21 Yin Y, Rohli KE, Shen P, Lu H, Liu Y, Dou Q, Zhang L, Kong X, Yang S, Jia P. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review. Prim Care Diabetes 2021;15:899-909. [PMID: 34600859 DOI: 10.1016/j.pcd.2021.08.014] [Reference Citation Analysis]
22 Zheng KL, Xu Y, Guo YF, Diao L, Kong XY, Wan XJ, Zhao F, Ning FZ, Wang LB, Qiao F, Zhao JM, Zhou JH, Zhong YQ, Wu SX, Chen Y, Jin G, Dong YC. Efficacy and safety of tocilizumab in COVID-19 patients. Aging (Albany NY) 2020;12:18878-88. [PMID: 33031060 DOI: 10.18632/aging.103988] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Peiró ÓM, Carrasquer A, Sánchez-Gimenez R, Lal-Trehan N, Del-Moral-Ronda V, Bonet G, Fort-Gallifa I, Picó-Plana E, Bastón-Paz N, Gutiérrez C, Bardaji A. Biomarkers and short-term prognosis in COVID-19. Biomarkers 2021;26:119-26. [PMID: 33426934 DOI: 10.1080/1354750X.2021.1874052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Mulchandani R, Lyngdoh T, Kakkar AK. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13429. [PMID: 33058143 DOI: 10.1111/eci.13429] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
25 Hong LZ, Shou ZX, Zheng DM, Jin X. The most important biomarker associated with coagulation and inflammation among COVID-19 patients. Mol Cell Biochem 2021;476:2877-85. [PMID: 33742367 DOI: 10.1007/s11010-021-04122-4] [Reference Citation Analysis]
26 Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, Hsu AT, Ishak IA, Nur AA, Ayeh SK, Salia EL, Zil-E-Ali A, Saeed MA, Sarena APB, Seth B, Ahmadzada M, Haque EF, Neupane P, Wang KH, Pu TM, Ali SMH, Arshad MA, Wang L, Baksh S, Karakousis PC, Galiatsatos P. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.PLoS One. 2020;15:e0241541. [PMID: 33206661 DOI: 10.1371/journal.pone.0241541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
27 Asghar MS, Haider Kazmi SJ, Khan NA, Akram M, Hassan M, Rasheed U, Ahmed Khan S. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country. Cureus 2020;12:e9575. [PMID: 32913691 DOI: 10.7759/cureus.9575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 2020;14:1753466620937175. [PMID: 32615866 DOI: 10.1177/1753466620937175] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 55.0] [Reference Citation Analysis]
29 Acar HC, Can G, Karaali R, Börekçi Ş, Balkan İİ, Gemicioğlu B, Konukoğlu D, Erginöz E, Erdoğan MS, Tabak F. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital. BMC Infect Dis 2021;21:148. [PMID: 33546639 DOI: 10.1186/s12879-021-05845-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Xiang HX, Fei J, Xiang Y, Xu Z, Zheng L, Li XY, Fu L, Zhao H. Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study. BMC Infect Dis 2021;21:158. [PMID: 33557785 DOI: 10.1186/s12879-021-05861-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Juneja D, Savio RD, Srinivasan S, Pandit RA, Ramasubban S, Reddy PK, Singh M, Gopal PB, Chaudhry D, Govil D, Dixit S, Samavedam S. Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I. Indian J Crit Care Med 2020;24:S244-53. [PMID: 33354048 DOI: 10.5005/jp-journals-10071-23601] [Reference Citation Analysis]
32 Che L, Wang Z, Du N, Li L, Zhao Y, Zhang K, Liu Q. Evaluation of Serum Ferritin, Procalcitonin, and C-Reactive Protein for the Prediction of Severity and Mortality in Hemorrhagic Fever With Renal Syndrome. Front Microbiol 2022;13:865233. [PMID: 35677912 DOI: 10.3389/fmicb.2022.865233] [Reference Citation Analysis]
33 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
34 Rawat D, Roy A, Maitra S, Shankar V, Khanna P, Baidya DK. "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis". Diabetes Metab Syndr 2021;15:102189. [PMID: 34217144 DOI: 10.1016/j.dsx.2021.102189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ma X, Ng M, Xu S, Xu Z, Qiu H, Liu Y, Lyu J, You J, Zhao P, Wang S, Tang Y, Cui H, Yu C, Wang F, Shao F, Sun P, Tang Z. Development and validation of prognosis model of mortality risk in patients with COVID-19. Epidemiol Infect 2020;148:e168. [PMID: 32746957 DOI: 10.1017/S0950268820001727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
36 Mason CY, Kanitkar T, Richardson CJ, Lanzman M, Stone Z, Mahungu T, Mack D, Wey EQ, Lamb L, Balakrishnan I, Pollara G. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics. J Antimicrob Chemother 2021;76:1323-31. [PMID: 33463683 DOI: 10.1093/jac/dkaa563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
37 Qu J, Sumali B, Lee H, Terai H, Ishii M, Fukunaga K, Mitsukura Y, Nishimura T. Finding of the factors affecting the severity of COVID-19 based on mathematical models. Sci Rep 2021;11:24224. [PMID: 34930966 DOI: 10.1038/s41598-021-03632-x] [Reference Citation Analysis]
38 Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol 2020;267:3135-53. [PMID: 32561990 DOI: 10.1007/s00415-020-09990-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
39 Furqan MM, Verma BR, Cremer PC, Imazio M, Klein AL. Pericardial Diseases in COVID19: a Contemporary Review. Curr Cardiol Rep 2021;23:90. [PMID: 34081219 DOI: 10.1007/s11886-021-01519-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Suri A, Kaushik P, Yadav BB, Singh NK, Bansal SK, Kumari M. Is COVID-19 gender biased? Horm Mol Biol Clin Investig 2021. [PMID: 34821130 DOI: 10.1515/hmbci-2021-0060] [Reference Citation Analysis]
41 Ahirwar AK, Takhelmayum R, Sakarde A, Rathod BD, Jha PK, Kumawat R, Gopal N. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study. Horm Mol Biol Clin Investig 2022. [PMID: 35357792 DOI: 10.1515/hmbci-2021-0088] [Reference Citation Analysis]
42 Khaksarinejad R, Arabpour Z, RezaKhani L, Parvizpour F, Rasmi Y. Biomarker based biosensors: An opportunity for diagnosis of COVID-19. Rev Med Virol 2022;:e2356. [PMID: 35478470 DOI: 10.1002/rmv.2356] [Reference Citation Analysis]
43 Asmarawati TP, Suryantoro SD, Rosyid AN, Marfiani E, Windradi C, Mahdi BA, Sutanto H. Predictive Value of Sequential Organ Failure Assessment (SOFA), Quick Sequential Organ Failure Assessment (qSOFA), Acute Physiology and Chronic Health Evaluation (APACHE II), and New Early Warning Signs (NEWS-2) Scores Estimate Mortality of COVID-19 Patients Requiring Intensive Care Unit (ICU). Indian Journal of Critical Care Medicine 2022;26:464-71. [DOI: 10.5005/jp-journals-10071-24170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Romadhon PZ, Bintoro SUY, Suryantoro SD, Asmarawati TP, Nur Rosyid A, Savitri M, Amrita PNA, Diansyah MN, Prayoga AA, Windradi C, Mahdi BA, Widiyastuti KN, Novendrianto D, Agustin ED, Alkaff FF, Prahasanti K, Dewanto DD. The improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients: a cross-sectional study from two second referral hospitals in Surabaya, Indonesia. F1000Res 2022;11:61. [DOI: 10.12688/f1000research.75135.2] [Reference Citation Analysis]
45 Pitre T, Jones A, Su J, Helmeczi W, Xu G, Lee C, Shamsuddin A, Mir A, MacGregor S, Duong M, Ho T, Beauchamp MK, Costa AP, Kruisselbrink R; COREG Investigators. Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study. Intern Emerg Med 2021;16:1573-82. [PMID: 33496923 DOI: 10.1007/s11739-021-02637-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
46 Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol 2020;4:65. [PMID: 33123675 DOI: 10.1186/s41927-020-00165-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
47 Ebinger J, Wells M, Ouyang D, Davis T, Kaufman N, Cheng S, Chugh S. A Machine Learning Algorithm Predicts Duration of hospitalization in COVID-19 patients. Intell Based Med 2021;5:100035. [PMID: 34075366 DOI: 10.1016/j.ibmed.2021.100035] [Reference Citation Analysis]
48 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Reference Citation Analysis]
49 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
50 Valencia-Sanchez C, Flanagan EP. COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? - Commentary. Mult Scler 2021;27:976-7. [PMID: 32909889 DOI: 10.1177/1352458520958357] [Reference Citation Analysis]
51 Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review. Life (Basel) 2021;11:784. [PMID: 34440528 DOI: 10.3390/life11080784] [Reference Citation Analysis]
52 Zhang B, Tian J, Zhang Q, Xie Y, Wang K, Qiu S, Lu K, Liu Y. Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug. Front Mol Biosci 2022;9:761173. [DOI: 10.3389/fmolb.2022.761173] [Reference Citation Analysis]
53 Mishra M, Zahra A, Chauhan LV, Thakkar R, Ng J, Joshi S, Spitzer ED, Marcos LA, Lipkin WI, Mishra N. A Short Series of Case Reports of COVID-19 in Immunocompromised Patients. Viruses 2022;14:934. [PMID: 35632677 DOI: 10.3390/v14050934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Liu ZM, Li JP, Wang SP, Chen DY, Zeng W, Chen SC, Huang YH, Huang JL, Long W, Li M, Gao RF, Guo L, Wu XH. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19. Int J Med Sci 2020;17:2468-76. [PMID: 33029089 DOI: 10.7150/ijms.48396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
55 Jackson I, Jaradeh H, Aurit S, Aldamen A, Narechania S, Destache C, Velagapudi M. Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19. Int J Infect Dis 2022;119:47-52. [PMID: 35358722 DOI: 10.1016/j.ijid.2022.03.044] [Reference Citation Analysis]
56 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Reference Citation Analysis]
58 [DOI: 10.1101/2020.08.04.20167205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Nasonov EL. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6. Naučno-praktičeskaâ revmatologiâ 2020;58:245-61. [DOI: 10.14412/1995-4484-2020-245-261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
61 [DOI: 10.1101/2020.07.02.20143271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Tomo S, Banerjee M, Sharma P, Garg M. Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment? Endocr Regul 2021;55:174-81. [PMID: 34523302 DOI: 10.2478/enr-2021-0019] [Reference Citation Analysis]
63 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med 2021;10:1545. [PMID: 33916917 DOI: 10.3390/jcm10081545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Darmadi D, Pakpahan C, Ruslie RH, Rezano A. Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study. F1000Res 2021;10:1246. [PMID: 35136584 DOI: 10.12688/f1000research.74758.2] [Reference Citation Analysis]
65 Wanhella KJ, Fernandez-Patron C. Biomarkers of ageing and frailty may predict COVID-19 severity. Ageing Res Rev 2022;73:101513. [PMID: 34838734 DOI: 10.1016/j.arr.2021.101513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Imani MM, Sadeghi M, Farokhzadeh F, Khazaie H, Brand S, Dürsteler KM, Brühl A, Sadeghi-Bahmani D. Evaluation of Blood Levels of C-Reactive Protein Marker in Obstructive Sleep Apnea: A Systematic Review, Meta-Analysis and Meta-Regression. Life (Basel) 2021;11:362. [PMID: 33921787 DOI: 10.3390/life11040362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Vrbacky F, Fatorova I, Blazek M, Smahel P, Zak P. Intensive Care Infection Score (ICIS) is elevated in patients with moderate and severe COVID-19 in the early stages of disease. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.03.018] [Reference Citation Analysis]
68 Zheng Y, Jin, Lin J, Zhang Y, Tian J, Lian F, Tong X. Understanding COVID-19 in Wuhan From the Perspective of Cold-Dampness: Clinical Evidences and Mechanisms. Front Med (Lausanne) 2021;8:617659. [PMID: 33693014 DOI: 10.3389/fmed.2021.617659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Naumov V, Putin E, Pushkov S, Kozlova E, Romantsov K, Kalashnikov A, Galkin F, Tihonova N, Shneyderman A, Galkin E, Zinkevich A, Cope SM, Sethuraman R, Oprea TI, Pearson AT, Tay S, Agrawal N, Dubovenko A, Vanhaelen Q, Ozerov I, Aliper A, Izumchenko E, Zhavoronkov A. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity. PLoS Comput Biol 2021;17:e1009183. [PMID: 34260589 DOI: 10.1371/journal.pcbi.1009183] [Reference Citation Analysis]
70 Tanak AS, Sardesai A, Muthukumar S, Prasad S. Simultaneous detection of sepsis host response biomarkers in whole blood using electrochemical biosensor. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10310] [Reference Citation Analysis]
71 Li J, Sun L, Wang F, Liu B, Li H, Tang G, Chang Z, Liu A, Fu C, Lv Y, Gao J, Li J. Relation between Cardiac Injury and Elevated Levels of Inflammatory Biomarkers in Patients with Severe COVID-19. Cardiovascular Innovations and Applications 2021;5:165-72. [DOI: 10.15212/cvia.2019.1264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Almeida Junior GLG, Braga F, Jorge JK, Nobre GF, Kalichsztein M, Faria PMP, Bussade B, Penna GL, Alves VO, Pereira MA, Gorgulho PC, Faria MRDSE, Drumond LE, Carpinete FBS, Neno ACLB, Neno ACA. Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19. Arq Bras Cardiol 2020;115:660-6. [PMID: 33111866 DOI: 10.36660/abc.20200385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
73 Asalkar M, Thakkarwad S, Rumani I, Sharma N. Prevalence of Maternal Mortality and Clinical Course of Maternal Deaths in COVID-19 Pneumonia-A Cross-Sectional Study. J Obstet Gynaecol India 2021;:1-10. [PMID: 34629786 DOI: 10.1007/s13224-021-01545-3] [Reference Citation Analysis]
74 Asghar MS, Ahmed I, Alvi H, Iqbal S, Khan I, Alvi RS, Saeed Z, Irfan S, Akhtar M, Fatima I. Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19. J Community Hosp Intern Med Perspect 2021;11:9-16. [PMID: 33552406 DOI: 10.1080/20009666.2020.1835214] [Reference Citation Analysis]
75 Suryantoro SD, Thaha M, Hayati MR, Yusuf M, Pikir BS, Susilo H. Correlation between anti-hypertensive drugs and disease progression among moderate, severe, and critically ill COVID-19 patients in the second referral hospital in Surabaya: A retrospective cohort study. F1000Res 2021;10:393. [PMID: 34912542 DOI: 10.12688/f1000research.51785.2] [Reference Citation Analysis]
76 Rajyalakshmi B, Samavedam S, Reddy PR, Aluru N. Prognostic Value of "Cycle Threshold" in Confirmed COVID-19 Patients. Indian J Crit Care Med 2021;25:322-6. [PMID: 33790515 DOI: 10.5005/jp-journals-10071-23765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Xiao LN, Ran X, Zhong YX, Li SS. Clinical value of blood markers to assess the severity of coronavirus disease 2019. BMC Infect Dis 2021;21:921. [PMID: 34488665 DOI: 10.1186/s12879-021-06623-5] [Reference Citation Analysis]
78 Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet 2021;303:337-45. [PMID: 33258995 DOI: 10.1007/s00404-020-05889-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
79 Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, Ceirano A, Espinosa F, Saavedra E, Sanguine V, Tassara A, Cid C, Catalano HN, Agarwal A, Foroutan F, Rada G. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One 2020;15:e0241955. [PMID: 33201896 DOI: 10.1371/journal.pone.0241955] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 35.5] [Reference Citation Analysis]
80 Presnyakova MV, Galova EA, Sosnina LN, Popovicheva AN, Lyubavina NA, Kostina OV, Kuznetsova VL, Karyakin NN. Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia. Klin Lab Diagn 2020;65:744-9. [PMID: 33373505 DOI: 10.18821/0869-2084-2020-65-12-744-749] [Reference Citation Analysis]
81 Manganotti P, Bellavita G, Tommasini V, D Acunto L, Fabris M, Cecotti L, Furlanis G, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients. J Med Virol 2021;93:5432-7. [PMID: 33951196 DOI: 10.1002/jmv.27061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Qu J, Zhu HH, Huang XJ, He GF, Liu JY, Huang JJ, Chen Y, Qu Q, Wu YL, Chen XY, Lu Q. Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients. Infect Drug Resist 2021;14:3029-40. [PMID: 34408447 DOI: 10.2147/IDR.S321915] [Reference Citation Analysis]
83 Torzewski J, Brunner P, Ries W, Garlichs CD, Kayser S, Heigl F, Sheriff A. Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons. J Clin Med 2022;11:1771. [PMID: 35407379 DOI: 10.3390/jcm11071771] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 de Nooijer AH, Grondman I, Lambden S, Kooistra EJ, Janssen NAF, Kox M, Pickkers P, Joosten LAB, van de Veerdonk FL, Derive M, Gibot S, Netea MG; RCI-COVID-19 study group. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19. Biosci Rep 2021;41:BSR20210940. [PMID: 34195785 DOI: 10.1042/BSR20210940] [Reference Citation Analysis]
85 Lin SW, Shen CF, Liu CC, Cheng CM. A Paper-Based IL-6 Test Strip Coupled With a Spectrum-Based Optical Reader for Differentiating Influenza Severity in Children. Front Bioeng Biotechnol 2021;9:752681. [PMID: 34692664 DOI: 10.3389/fbioe.2021.752681] [Reference Citation Analysis]
86 Liang J, Nong S, Jiang L, Chi X, Bi D, Cao J, Mo L, Luo X, Huang H. Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment. J Clin Lab Anal 2021;35:e23609. [PMID: 33222271 DOI: 10.1002/jcla.23609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Rzymski P, Poniedziałek B, Rosińska J, Rogalska M, Zarębska-Michaluk D, Rorat M, Moniuszko-Malinowska A, Lorenc B, Kozielewicz D, Piekarska A, Sikorska K, Dworzańska A, Bolewska B, Angielski G, Kowalska J, Podlasin R, Oczko-Grzesik B, Mazur W, Szymczak A, Flisiak R. The association of airborne particulate matter and benzo[a]pyrene with the clinical course of COVID-19 in patients hospitalized in Poland. Environ Pollut 2022;306:119469. [PMID: 35580710 DOI: 10.1016/j.envpol.2022.119469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Sweeney JM, Barouqa M, Krause GJ, Gonzalez-Lugo JD, Rahman S, Gil MR. Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients. TH Open 2021;5:e89-e103. [PMID: 33709050 DOI: 10.1055/s-0041-1723784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
89 Rasmi Y, Mosa OF, Alipour S, Heidari N, Javanmard F, Golchin A, Gholizadeh-ghaleh Aziz S. Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update. Front Mol Biosci 2022;9:821155. [DOI: 10.3389/fmolb.2022.821155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Wrotek A, Wrotek O, Jackowska T. Low Levels of Procalcitonin Are Related to Decreased Antibiotic Use in Children Hospitalized Due to Influenza. Diagnostics 2022;12:1148. [DOI: 10.3390/diagnostics12051148] [Reference Citation Analysis]
91 Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25:77-84. [PMID: 33603306 DOI: 10.5005/jp-journals-10071-23706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
92 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, España PP, Quintana JM, García-Gutiérrez S; COVID-19-Osakidetza working group. Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study. Rev Clin Esp (Barc) 2021:S2254-8874(21)00149-1. [PMID: 34556435 DOI: 10.1016/j.rceng.2021.04.009] [Reference Citation Analysis]
93 [DOI: 10.1101/2020.09.03.20187252] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
94 Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, Berger JS. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J 2021;42:2270-9. [PMID: 33448289 DOI: 10.1093/eurheartj/ehaa1103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
95 Tamimi F, Altigani S, Sanz M. Periodontitis and coronavirus disease 2019. Periodontol 2000 2022. [PMID: 35244975 DOI: 10.1111/prd.12434] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
96 Yitao Z, Mu C, Ling Z, Shiyao C, Jiaojie X, Zhichong C, Huajing P, Maode O, Kanglin C, Mao OY, Xiaoneng M, Weijie Z. Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study. Curr Med Res Opin 2021;37:385-91. [PMID: 33459077 DOI: 10.1080/03007995.2021.1876005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 González-García JG, Pascual-Guardia S, Aguilar Colindres RJ, Ausín Herrero P, Alvarado Miranda M, Arita Guevara M, Badenes Bonet D, Bellido Calduch S, Caguana Vélez OA, Cumpli Gargallo C, Dominguez-Alvarez M, Gea J, Grau N, Khilzi K, Martínez-Llorens J, Sánchez Ortiz M, Sánchez-Font A, Sancho-Muñoz A, Parrilla-Gómez FJ, Marín Corral J, Pérez Terán P, Rodríguez-Sevilla JJ, Chalela R, Rodríguez-Chiaradia D. Incidence of pulmonary embolism in patients with non-invasive respiratory support during COVID-19 outbreak. Respir Med 2021;178:106325. [PMID: 33581510 DOI: 10.1016/j.rmed.2021.106325] [Reference Citation Analysis]
98 Akbas EM, Akbas N. COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:1-7. [PMID: 33542545 DOI: 10.5507/bp.2021.011] [Reference Citation Analysis]
99 Diaz-Louzao C, Barrera-Lopez L, Lopez-Rodriguez M, Casar C, Vazquez-Agra N, Pernas-Pardavila H, Marques-Afonso A, Vidal-Vazquez M, Montoya JG, Andrade AH, Fernandez-Castro I, Varela P, Gonzalez-Quintela A, Otero E, Gude F, Cadarso-Suarez C, Tome S. Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach. Sci Rep 2022;12:5547. [PMID: 35365705 DOI: 10.1038/s41598-022-09290-x] [Reference Citation Analysis]
100 Rawat D, Roy A, Maitra S, Gulati A, Khanna P, Baidya DK. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2021;15:102324. [PMID: 34739908 DOI: 10.1016/j.dsx.2021.102324] [Reference Citation Analysis]
101 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 [DOI: 10.1101/2020.07.20.20157891] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
103 Gupta K, Gandhi S, Mebane A 3rd, Singh A, Vishnuvardhan N, Patel E. Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward. Cancer Treat Res Commun 2021;26:100285. [PMID: 33360669 DOI: 10.1016/j.ctarc.2020.100285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
104 Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, Moudi E, Rostami A, Barary M, Hosseini A, Bijani A, Javanian M. C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdiscip Perspect Infect Dis 2021;2021:5557582. [PMID: 33968148 DOI: 10.1155/2021/5557582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Vivarelli S, Falzone L, Torino F, Scandurra G, Russo G, Bordonaro R, Pappalardo F, Spandidos DA, Raciti G, Libra M. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review). Int J Oncol 2021;58:145-57. [PMID: 33491759 DOI: 10.3892/ijo.2020.5159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
106 Aversa M, Benvenuto L, Anderson M, Shah L, Robbins H, Pereira M, Scheffert J, Carroll M, Hum J, Nolan M, Reilly G, Lemaitre P, Stanifer BP, D'Ovidio F, Sonett J, Arcasoy S; From the Columbia University Lung Transplant Program. COVID-19 in lung transplant recipients: A single center case series from New York City. Am J Transplant 2020;20:3072-80. [PMID: 32881315 DOI: 10.1111/ajt.16241] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
107 Zhai W, Luo Z, Zheng Y, Dong D, Wu E, Wang Z, Zhai J, Han Y, Liu H, Wang Y, Feng Y, Wang J, Ma Y. Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study. Sci Rep 2021;11:6483. [PMID: 33753799 DOI: 10.1038/s41598-021-85869-0] [Reference Citation Analysis]
108 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
109 Hejazi ME, Malek Mahdavi A, Navarbaf Z, Tarzamni MK, Moradi R, Sadeghi A, Valizadeh H, Namvar L. Relationship between chest CT scan findings with SOFA score, CRP, comorbidity, and mortality in ICU patients with COVID-19. Int J Clin Pract 2021;:e14869. [PMID: 34525236 DOI: 10.1111/ijcp.14869] [Reference Citation Analysis]
110 Mosquera-Sulbaran JA, Pedreañez A, Carrero Y, Callejas D. C-reactive protein as an effector molecule in Covid-19 pathogenesis. Rev Med Virol 2021;31:e2221. [PMID: 34773448 DOI: 10.1002/rmv.2221] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
111 Sun H, Guo P, Zhang L, Wang F. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020. Med Sci Monit 2020;26:e926941. [PMID: 33175722 DOI: 10.12659/MSM.926941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
112 Fujino M, Ishii M, Taniguchi T, Chiba H, Kimata M, Hitosugi M. The Value of Interleukin-6 among Several Inflammatory Markers as a Predictor of Respiratory Failure in COVID-19 Patients. Diagnostics (Basel) 2021;11:1327. [PMID: 34441262 DOI: 10.3390/diagnostics11081327] [Reference Citation Analysis]
113 Sayah W, Berkane I, Guermache I, Sabri M, Lakhal FZ, Yasmine Rahali S, Djidjeli A, Lamara Mahammed L, Merah F, Belaid B, Berkani L, Lazli NZ, Kheddouci L, Kadi A, Ouali M, Khellafi R, Mekideche D, Kheliouen A, Hamidi RM, Ayoub S, Raaf NB, Derrar F, Gharnaout M, Allam I, Djidjik R. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine 2021;141:155428. [PMID: 33550165 DOI: 10.1016/j.cyto.2021.155428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
114 Patil SV, Gondhali G, Acharya A. Role of initial and follow-up IL-6 (Interleukin-6) titre in COVID-19 pneumonia: A single center experience. ELECTRON J GEN MED 2022;19:em390. [DOI: 10.29333/ejgm/12191] [Reference Citation Analysis]
115 Elshazli RM, Kline A, Elgaml A, Aboutaleb MH, Salim MM, Omar M, Munshi R, Mankowski N, Hussein MH, Attia AS, Toraih EA, Settin A, Killackey M, Fawzy MS, Kandil E. Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves. J Med Virol 2021;93:2740-68. [PMID: 33527440 DOI: 10.1002/jmv.26836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
116 Park SJ, Nam DE, Seong HC, Hahn YS. New Discovery of Myeloid-Derived Suppressor Cell's Tale on Viral Infection and COVID-19. Front Immunol 2022;13:842535. [PMID: 35185933 DOI: 10.3389/fimmu.2022.842535] [Reference Citation Analysis]
117 Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
118 Cakir Guney B, Hayiroglu M, Senocak D, Cicek V, Cinar T, Kaplan M. Evaluation of N/LP Ratio as a Predictor of Disease Progression and Mortality in COVID-19 Patients Admitted to the Intensive Care Unit. Medeni Med J 2021;36:241-8. [PMID: 34915683 DOI: 10.5222/MMJ.2021.95676] [Reference Citation Analysis]
119 Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem 2020;39:500-7. [PMID: 33312067 DOI: 10.5937/jomb0-27554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
120 Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10. [PMID: 32845042 DOI: 10.1002/rmv.2146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 20.0] [Reference Citation Analysis]
121 Alharthy A, Faqihi F, Memish ZA, Balhamar A, Nasim N, Shahzad A, Tamim H, Alqahtani SA, Brindley PG, Karakitsos D. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series. Artif Organs 2021;45:E101-12. [PMID: 33190288 DOI: 10.1111/aor.13864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
122 Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Timberlake DT, Strothman K, Grayson MH. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019. Curr Opin Allergy Clin Immunol 2021;21:182-7. [PMID: 33399389 DOI: 10.1097/ACI.0000000000000720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Huang P, Zuo Q, Li Y, Oduro PK, Tan F, Wang Y, Liu X, Li J, Wang Q, Guo F, Li Y, Yang L. A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients. Front Immunol 2022;13:930673. [DOI: 10.3389/fimmu.2022.930673] [Reference Citation Analysis]
125 Pulia MS, Wolf I, Schulz LT, Pop-Vicas A, Schwei RJ, Lindenauer PK. COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department. West J Emerg Med 2020;21:1283-6. [PMID: 32970587 DOI: 10.5811/westjem.2020.7.48848] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
126 Ahmed Mostafa G, Mohamed Ibrahim H, Al Sayed Shehab A, Mohamed Magdy S, Aboabdoun Soliman N, Fathy El-sherif D. Up-regulated serum levels of interleukin (IL)-17A and IL-22 in Egyptian pediatric patients with COVID-19 and MIS-C: Relation to the disease outcome. Cytokine 2022;154:155870. [DOI: 10.1016/j.cyto.2022.155870] [Reference Citation Analysis]
127 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
128 Forget MF, Del Degan S, Leblanc J, Tannous R, Desjardins M, Durand M, Vu TTM, Nguyen QD, Desmarais P. Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study. Clin Interv Aging 2021;16:1223-30. [PMID: 34234422 DOI: 10.2147/CIA.S315405] [Reference Citation Analysis]
129 Abdelsalam M, Althaqafi RMM, Assiri SA, Althagafi TM, Althagafi SM, Fouda AY, Ramadan A, Rabah M, Ahmed RM, Ibrahim ZS, Nemenqani DM, Alghamdi AN, Al Aboud D, Abdel-Moneim AS, Alsulaimani AA. Clinical and Laboratory Findings of COVID-19 in High-Altitude Inhabitants of Saudi Arabia. Front Med (Lausanne) 2021;8:670195. [PMID: 34055842 DOI: 10.3389/fmed.2021.670195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Zhang S, Huang S, Liu J, Dong X, Meng M, Chen L, Wen Z, Zhang L, Chen Y, Du H, Liu Y, Wang T, Chen D. Identification and validation of prognostic factors in patients with COVID-19: A retrospective study based on artificial intelligence algorithms. Journal of Intensive Medicine 2021;1:103-9. [DOI: 10.1016/j.jointm.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
131 Waris A, Din M, Iqbal N, Yar L, Khalid A, Nawaz M, Baset A, Ali M. Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients. New Microbes New Infect 2021;43:100922. [PMID: 34336223 DOI: 10.1016/j.nmni.2021.100922] [Reference Citation Analysis]
132 Wungu CDK, Khaerunnisa S, Putri EAC, Hidayati HB, Qurnianingsih E, Lukitasari L, Humairah I, Soetjipto. Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19. Int J Infect Dis 2021;105:551-9. [PMID: 33711519 DOI: 10.1016/j.ijid.2021.03.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
133 Manzanares W, Moreira E, Hardy G. Pharmaconutrition revisited for critically ill patients with coronavirus disease 2019 (COVID-19): Does selenium have a place? Nutrition 2021;81:110989. [PMID: 33049573 DOI: 10.1016/j.nut.2020.110989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
134 Zhang J, Gao XL, Yang LH. [Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19]. Zhonghua Xue Ye Xue Za Zhi 2021;42:700-4. [PMID: 34547883 DOI: 10.3760/cma.j.issn.0253-2727.2021.08.019] [Reference Citation Analysis]
135 Evans TJ, Davidson HC, Low JM, Basarab M, Arnold A. Antibiotic usage and stewardship in patients with COVID-19: too much antibiotic in uncharted waters? J Infect Prev 2021;22:119-25. [PMID: 34239610 DOI: 10.1177/1757177420976813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 de Bruin S, Bos LD, van Roon MA, Tuip-de Boer AM, Schuurman AR, Koel-Simmelinck MJA, Bogaard HJ, Tuinman PR, van Agtmael MA, Hamann J, Teunissen CE, Wiersinga WJ, Koos Zwinderman AH, Brouwer MC, van de Beek D, Vlaar APJ; Amsterdam UMC COVID-19 Biobank Investigators. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 2021;67:103378. [PMID: 34000622 DOI: 10.1016/j.ebiom.2021.103378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
137 Feng J, Fang B, Zhou D, Wang J, Zou D, Yu G, Fen Y, Peng D, Hu J, Zhan D. Clinical Effect of Traditional Chinese Medicine Shenhuang Granule in Critically Ill Patients with COVID-19: A Single-Centered, Retrospective, Observational Study. J Microbiol Biotechnol 2021;31:380-6. [PMID: 33746189 DOI: 10.4014/jmb.2009.09029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J. COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review. Front Psychiatry 2021;12:798554. [PMID: 35095612 DOI: 10.3389/fpsyt.2021.798554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197-206. [PMID: 33063089 DOI: 10.1093/cvr/cvaa284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
140 Zolfaghari Emameh R, Nosrati H, Eftekhari M, Falak R, Khoshmirsafa M. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19. Biol Proced Online 2020;22:16. [PMID: 32754004 DOI: 10.1186/s12575-020-00127-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
141 Kitakata H, Kohsaka S, Kuroda S, Nomura A, Kitai T, Yonetsu T, Torii S, Matsue Y, Matsumoto S. Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients. J Clin Med 2021;10:3086. [PMID: 34300252 DOI: 10.3390/jcm10143086] [Reference Citation Analysis]
142 Duecker RP, Adam EH, Wirtz S, Gronau L, Khodamoradi Y, Eberhardt FJ, Donath H, Gutmann D, Vehreschild MJGT, Zacharowski K, Kreyenberg H, Chiocchetti AG, Zielen S, Schubert R. The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure. Int J Mol Sci 2021;22:10351. [PMID: 34638691 DOI: 10.3390/ijms221910351] [Reference Citation Analysis]
143 Scotto R, Pinchera B, Perna F, Atripaldi L, Giaccone A, Sequino D, Zappulo E, Sardanelli A, Schiano Moriello N, Stanziola A, Bocchino M, Gentile I, Sanduzzi A. Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia. Int J Environ Res Public Health 2021;18:2078. [PMID: 33672761 DOI: 10.3390/ijerph18042078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
144 Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC, Zingaropoli MA, Ciardi MR, Mastroianni CM, Pugliese F, Alessandri F, Turriziani O, Ricci P, Catalano C. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol 2020;30:6808-17. [PMID: 32623505 DOI: 10.1007/s00330-020-07033-y] [Cited by in Crossref: 135] [Cited by in F6Publishing: 102] [Article Influence: 67.5] [Reference Citation Analysis]
145 Faverio P, Ornaghi S, Stainer A, Invernizzi F, Borelli M, Brunetti F, La Milia L, Paolini V, Rona R, Foti G, Luppi F, Vergani P, Pesci A. Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre. PLoS One 2021;16:e0258754. [PMID: 34665818 DOI: 10.1371/journal.pone.0258754] [Reference Citation Analysis]
146 Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, Labrique A, Mohan D. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One 2021;16:e0247461. [PMID: 33661992 DOI: 10.1371/journal.pone.0247461] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 35.0] [Reference Citation Analysis]
147 Gomez Hernandez MP, Starman EE, Davis AB, Harishchandra Hikkaduwa Withanage M, Zeng E, Lieberman SM, Brogden KA, Lanzel EA. A distinguishing profile of chemokines, cytokines, and biomarkers in the saliva of children with Sjögren's syndrome. Rheumatology (Oxford) 2021:keab098. [PMID: 33512494 DOI: 10.1093/rheumatology/keab098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
148 Liu C, Martins AJ, Lau WW, Rachmaninoff N, Chen J, Imberti L, Mostaghimi D, Fink DL, Burbelo PD, Dobbs K, Delmonte OM, Bansal N, Failla L, Sottini A, Quiros-Roldan E, Han KL, Sellers BA, Cheung F, Sparks R, Chun TW, Moir S, Lionakis MS, Rossi C, Su HC, Kuhns DB, Cohen JI, Notarangelo LD, Tsang JS; NIAID COVID Consortium., COVID Clinicians. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 2021;184:1836-1857.e22. [PMID: 33713619 DOI: 10.1016/j.cell.2021.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
149 Weidmann MD, Ofori K, Rai AJ. Laboratory Biomarkers in the Management of Patients With COVID-19. Am J Clin Pathol 2021;155:333-42. [PMID: 33107558 DOI: 10.1093/ajcp/aqaa205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
150 K.rostam SR, Shekhany KAM, Smail HO. COMPARATIVE STUDY of SOME BIOCHEMICAL PARAMETERS AMONG of COVID-19 SYMPTOMS and NON COVID-19 SYMPTOMS IN-DIVIDUALS. BIOV 2020;6. [DOI: 10.24233/biov.6.2.2020.180] [Reference Citation Analysis]
151 Attia AS, Hussein M, Aboueisha MA, Omar M, Youssef MR, Mankowski N, Miller M, Munshi R, Swinford A, Kline A, Nguyen T, Toraih E, Duchesne J, Kandil E. Altered mental status is a predictor of poor outcomes in COVID-19 patients: A cohort study. PLoS One 2021;16:e0258095. [PMID: 34610034 DOI: 10.1371/journal.pone.0258095] [Reference Citation Analysis]
152 Eidizadeh A, Wiederhold M, Schnelle M, Binder L. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays. Practical Laboratory Medicine 2022;30:e00274. [DOI: 10.1016/j.plabm.2022.e00274] [Reference Citation Analysis]
153 Stoeckle K, Witting B, Kapadia S, An A, Marks K. Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir. J Med Virol 2022;94:384-7. [PMID: 34406670 DOI: 10.1002/jmv.27280] [Reference Citation Analysis]
154 Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scand J Immunol 2021;93:e13039. [PMID: 33710663 DOI: 10.1111/sji.13039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
155 Avila-Nava A, Cortes-Telles A, Torres-Erazo D, López-Romero S, Chim Aké R, Gutiérrez Solis AL. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico. Cytokine 2021;143:155543. [PMID: 33896708 DOI: 10.1016/j.cyto.2021.155543] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
156 McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS 2021;18:32. [PMID: 34261487 DOI: 10.1186/s12987-021-00267-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Yu X, Xu X, Wu T, Huang W, Xu C, Xie W, Long X. APOA1 Level is Negatively Correlated with the Severity of COVID-19. IJGM 2022;Volume 15:689-98. [DOI: 10.2147/ijgm.s332956] [Reference Citation Analysis]
158 Chen X, Zhou J, Chen C, Hou B, Ali A, Li F, Hua Z, Wu Y, Yang Q, Chen M, Zhang R, Huang Q, Ding J, Zhang XE, Men D. Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients. Virol Sin 2021. [PMID: 34232450 DOI: 10.1007/s12250-021-00425-4] [Reference Citation Analysis]
159 Mitsumura T, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. SARS-CoV-2 RNA copy number is a factor associated with the mortality of COVID-19 and improves the predictive performance of mortality in severe cases. Jpn J Infect Dis 2022. [PMID: 35650037 DOI: 10.7883/yoken.JJID.2022.080] [Reference Citation Analysis]
160 Picchi G, Di Norcia M, Cofini V, Sinatti G, Cosimini B, Vertolli P, Tonello F, Carucci AC, Necozione S, Balsano C, Grimaldi A. Laboratory parameters related to severe disease and death in SARS-CoV-2 pneumonia: Retrospective analysis. J Med Virol 2021;93:5886-95. [PMID: 34138485 DOI: 10.1002/jmv.27141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Patel D, Kher V, Desai B, Lei X, Cen S, Nanda N, Gholamrezanezhad A, Duddalwar V, Varghese B, Oberai AA. Machine learning based predictors for COVID-19 disease severity. Sci Rep 2021;11:4673. [PMID: 33633145 DOI: 10.1038/s41598-021-83967-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
162 Faria SP, Carpinteiro C, Pinto V, Rodrigues SM, Alves J, Marques F, Lourenço M, Santos PH, Ramos A, Cardoso MJ, Guimarães JT, Rocha S, Sampaio P, Clifton DA, Mumtaz M, Paiva JS. Forecasting COVID-19 Severity by Intelligent Optical Fingerprinting of Blood Samples. Diagnostics (Basel) 2021;11:1309. [PMID: 34441244 DOI: 10.3390/diagnostics11081309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Wang YC, Lin SW, Wang IJ, Yang CY, Hong C, Sun JR, Feng PH, Lee MH, Shen CF, Lee YT, Cheng CM. Interleukin-6 Test Strip Combined With a Spectrum-Based Optical Reader for Early Recognition of COVID-19 Patients With Risk of Respiratory Failure. Front Bioeng Biotechnol 2022;10:796996. [PMID: 35242747 DOI: 10.3389/fbioe.2022.796996] [Reference Citation Analysis]
164 Cabler SS, French AR, Orvedahl A. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes. Trends Mol Med 2020;26:1078-85. [PMID: 33051104 DOI: 10.1016/j.molmed.2020.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
165 Chen Y, Zhi H, Zhang K, Zhu G, Liu L, Yan X, Cai Z, Zhao C, Hu Z. Combined predictive performance of age and neutrophilic percentage on admission for severe novel coronavirus disease 2019. Int J Clin Pract 2021;75:e14257. [PMID: 33884718 DOI: 10.1111/ijcp.14257] [Reference Citation Analysis]
166 Hasty F, García G, Dávila CH, Wittels SH, Hendricks S, Chong S. Heart Rate Variability as a Possible Predictive Marker for Acute Inflammatory Response in COVID-19 Patients. Mil Med 2020:usaa405. [PMID: 33206183 DOI: 10.1093/milmed/usaa405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
167 De Sanctis V. Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study. Acta Biomed 2020;91:e2020164. [PMID: 33525211 DOI: 10.23750/abm.v91i4.10540] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
168 García M, Kokkinou E, Carrasco García A, Parrot T, Palma Medina LM, Maleki KT, Christ W, Varnaitė R, Filipovic I, Ljunggren HG, Björkström NK, Folkesson E, Rooyackers O, Eriksson LI, Sönnerborg A, Aleman S, Strålin K, Gredmark-Russ S, Klingström J, Mjösberg J; Karolinska KI/K COVID‐19 Study Group. Innate lymphoid cell composition associates with COVID-19 disease severity. Clin Transl Immunology 2020;9:e1224. [PMID: 33343897 DOI: 10.1002/cti2.1224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
169 Joseph A, Zafrani L, Mabrouki A, Azoulay E, Darmon M. Acute kidney injury in patients with SARS-CoV-2 infection. Ann Intensive Care. 2020;10:117. [PMID: 32880774 DOI: 10.1186/s13613-020-00734-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
170 Tseng L, Hittesdorf E, Berman MF, Jordan DA, Yoh N, Elisman K, Eiseman KA, Miao Y, Wang S, Wagener G. Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score. Crit Care Res Pract 2021;2021:5585291. [PMID: 34123422 DOI: 10.1155/2021/5585291] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med 2021;46:382-91. [PMID: 33268238 DOI: 10.1016/j.ajem.2020.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 13.5] [Reference Citation Analysis]
172 Maier CL, Sarker T, Szlam F, Sniecinski RM. COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography. J Thromb Thrombolysis 2021. [PMID: 33829396 DOI: 10.1007/s11239-021-02438-y] [Reference Citation Analysis]
173 Slevin M, Molins B. Editorial: C-Reactive Protein in Age-Related Disorders, Volume II. Front Immunol 2022;13:876431. [PMID: 35350783 DOI: 10.3389/fimmu.2022.876431] [Reference Citation Analysis]
174 Çekiç D, Emir Arman M, Cihad Genç A, İşsever K, Yıldırım İ, Bilal Genç A, Dheir H, Yaylacı S. Predictive role of FAR ratio in COVID-19 patients. Int J Clin Pract 2021;75:e14931. [PMID: 34606668 DOI: 10.1111/ijcp.14931] [Reference Citation Analysis]
175 Kumano O, Akatsuchi K, Amiral J. Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants. Biomedicines 2021;9:264. [PMID: 33799956 DOI: 10.3390/biomedicines9030264] [Reference Citation Analysis]
176 Velavan TP, Kuk S, Linh LTK, Lamsfus Calle C, Lalremruata A, Pallerla SR, Kreidenweiss A, Held J, Esen M, Gabor J, Neurohr EM, Shamsrizi P, Fathi A, Biecker E, Berg CP, Ramharter M, Addo MM, Kreuels B, Kremsner PG. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients. Sci Rep 2021;11:14471. [PMID: 34262116 DOI: 10.1038/s41598-021-93950-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Damle L, Damle H, Br B. Plant formulation ATRICOV 452 in improving the level of COVID-19 specific inflammatory markers in patients. Contemporary Clinical Trials Communications 2022;28:100961. [DOI: 10.1016/j.conctc.2022.100961] [Reference Citation Analysis]
178 Vatansever HS, Becer E. Relationship between IL-6 and COVID-19: to be considered during treatment. Future Virology 2020;15:817-22. [DOI: 10.2217/fvl-2020-0168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Liang F, Wang X, Shao J, Chen J, Liu L, Li H, Xu Y, He L, Liang H, Li K, Gong S, Xia H. Comparison of clinical features on admission between coronavirus disease 2019 and influenza a among children: a retrospective study in China. BMC Infect Dis 2021;21:365. [PMID: 33865314 DOI: 10.1186/s12879-021-06037-3] [Reference Citation Analysis]
180 Virgens IPA, Santana NM, Lima SCVC, Fayh APT. Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations. Br J Nutr 2021;126:552-60. [PMID: 33261670 DOI: 10.1017/S0007114520004420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
181 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
182 Dąbrowska E, Galińska-Skok B, Waszkiewicz N. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life (Basel) 2021;11:1056. [PMID: 34685427 DOI: 10.3390/life11101056] [Reference Citation Analysis]
183 Alimoradi N, Sharqi M, Firouzabadi D, Sadeghi MM, Moezzi MI, Firouzabadi N. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease. Virol J 2022;19. [DOI: 10.1186/s12985-022-01782-6] [Reference Citation Analysis]
184 Vivarelli S, Falzone L, Grillo CM, Scandurra G, Torino F, Libra M. Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? Cancers (Basel) 2020;12:E2237. [PMID: 32785162 DOI: 10.3390/cancers12082237] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
185 Dos Anjos F, Simões JLB, Assmann CE, Carvalho FB, Bagatini MD. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2. J Immunol Res 2020;2020:8632048. [PMID: 33299899 DOI: 10.1155/2020/8632048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
186 Zhang Y, Xiao LS, Li P, Zhu H, Hu C, Zhang WF, Sun QC, Shen MY, Liu SS, Zhang WL, Zeng HY, Gong M, Liu L, He YL, Zhu H. Clinical Characteristics of Patients With Progressive and Non-progressive Coronavirus Disease 2019: Evidence From 365 Hospitalised Patients in Honghu and Nanchang, China. Front Med (Lausanne) 2020;7:556818. [PMID: 33304910 DOI: 10.3389/fmed.2020.556818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Mosselhy DA, Virtanen J, Kant R, He W, Elbahri M, Sironen T. COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles? Nanomaterials (Basel) 2021;11:796. [PMID: 33808934 DOI: 10.3390/nano11030796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
188 Burlacu R, London J, Fleury A, Sené T, Diallo A, Meyssonnier V, Zeller V, Galland J, Huscenot T, Rubenstein E, Trouiller P, Amathieu R, Kutter J, Blondeel D, Lejour G, Mouly S, Lidove O, Wladimir M, Sène D. No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study. Medicine (Baltimore) 2021;100:e26023. [PMID: 34032722 DOI: 10.1097/MD.0000000000026023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 Saji R, Nishii M, Sakai K, Miyakawa K, Yamaoka Y, Ban T, Abe T, Ohyama Y, Nakajima K, Hiromi T, Matsumura R, Suzuki N, Taniguchi H, Otsuka T, Oi Y, Ogawa F, Uchiyama M, Takahashi K, Iwashita M, Kimura Y, Fujii S, Furuya R, Tamura T, Ryo A, Takeuchi I. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One 2021;16:e0256022. [PMID: 34379684 DOI: 10.1371/journal.pone.0256022] [Reference Citation Analysis]
190 Palaiodimos L, Ali R, Teo HO, Parthasarathy S, Karamanis D, Chamorro-Pareja N, Kokkinidis DG, Kaur S, Kladas M, Sperling J, Chang M, Hupart K, Cha-Fong C, Srinivasan S, Kishore P, Davis N, Faillace RT. Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City. J Clin Med 2022;11:622. [PMID: 35160073 DOI: 10.3390/jcm11030622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
191 Omo-Aghoja L, Moke EG, Anachuna KK, Omogbiya AI, Umukoro EK, Toloyai PY, Daubry TME, Eduviere AT. COVID-19 pandemic: the implications of the natural history, challenges of diagnosis and management for care in sub-Saharan Africa. Beni Suef Univ J Basic Appl Sci 2021;10:16. [PMID: 33754124 DOI: 10.1186/s43088-021-00106-x] [Reference Citation Analysis]
192 Huang R, Xie L, He J, Dong H, Liu T. Association between the peripheral blood eosinophil counts and COVID-19: A meta-analysis. Medicine (Baltimore) 2021;100:e26047. [PMID: 34114990 DOI: 10.1097/MD.0000000000026047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Liu Z, Li J, Chen D, Gao R, Zeng W, Chen S, Huang Y, Huang J, Long W, Li M, Guo L, Wang X, Wu X. Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol 2020;11:1093. [PMID: 32765283 DOI: 10.3389/fphar.2020.01093] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
194 Bivona G, Agnello L, Ciaccio M. Biomarkers for Prognosis and Treatment Response in COVID-19 Patients. Ann Lab Med 2021;41:540-8. [PMID: 34108281 DOI: 10.3343/alm.2021.41.6.540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
195 Donlan AN, Sutherland TE, Marie C, Preissner S, Bradley BT, Carpenter RM, Sturek JM, Ma JZ, Moreau GB, Donowitz JR, Buck GA, Serrano MG, Burgess SL, Abhyankar MM, Mura C, Bourne PE, Preissner R, Young MK, Lyons GR, Loomba JJ, Ratcliffe SJ, Poulter MD, Mathers AJ, Day A, Mann BJ, Allen JE, Petri WA Jr. IL-13 is a driver of COVID-19 severity. medRxiv 2021:2020. [PMID: 33688686 DOI: 10.1101/2020.06.18.20134353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
196 Leulseged TW, Hassen IS, Ayele BT, Tsegay YG, Abebe DS, Edo MG, Maru EH, Zewde WC, Naylor LK, Semane DF, Dresse MT, Tezera BB. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country. PLoS One 2021;16:e0246087. [PMID: 33720944 DOI: 10.1371/journal.pone.0246087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
197 Keutmann M, Hermes G, Meinberger D, Roth A, Stemler J, Cornely OA, Klatt AR, Streichert T. The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13260-8] [Reference Citation Analysis]
198 Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, Shen JX, Sommerauer C, Tiseo G, Ghiadoni L, Virdis A, Monzani F, Rizos LR, Forfori F, Avendaño Céspedes A, De Marco S, Carrozzi L, Lena F, Sánchez-Jurado PM, Lacerenza LG, Cesira N, Caldevilla Bernardo D, Perrella A, Niccoli L, Méndez LS, Matarrese D, Goletti D, Tan YJ, Monteil V, Dranitsaris G, Cantini F, Farcomeni A, Dutta S, Burley SK, Zhang H, Pistello M, Li W, Romero MM, Andrés Pretel F, Simón-Talero RS, García-Molina R, Kutter C, Felce JH, Nizami ZF, Miklosi AG, Penninger JM, Menichetti F, Mirazimi A, Abizanda P, Lauschke VM. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv 2021;7:eabe4724. [PMID: 33187978 DOI: 10.1126/sciadv.abe4724] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 47.0] [Reference Citation Analysis]
199 Takamatsu C, Devis P, Tolouian R. COVID-19 and renal infarct: To be or not to be on anticoagulation. Clin Nephrol Case Stud 2021;9:117-22. [PMID: 34790516 DOI: 10.5414/CNCS110602] [Reference Citation Analysis]
200 Ravichandran R, Mohan SK, Sukumaran SK, Kamaraj D, Daivasuga SS, Ravi SOAS, Vijayaraghavalu S, Kumar RK. An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients. Sci Rep 2022;12:6413. [PMID: 35440611 DOI: 10.1038/s41598-022-10370-1] [Reference Citation Analysis]
201 Hu J, Wang Y. The Clinical Characteristics and Risk Factors of Severe COVID-19. Gerontology 2021;67:255-66. [PMID: 33406518 DOI: 10.1159/000513400] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
202 Mikacic M, Kumric M, Baricevic M, Tokic D, Stojanovic Stipic S, Cvitkovic I, Supe Domic D, Ticinovic Kurir T, Bozic J. Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients. JCM 2022;11:3699. [DOI: 10.3390/jcm11133699] [Reference Citation Analysis]
203 Ruiz-Rodríguez JC, Molnar Z, Deliargyris EN, Ferrer R. The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences. Crit Care Res Pract 2021;2021:7769516. [PMID: 34336280 DOI: 10.1155/2021/7769516] [Reference Citation Analysis]
204 Lim SYC, Zhou YP, Yii D, Chin DZ, Hung KC, Lee LW, Lim JL, Loo LW, Koomanan N, Chua NG, Liew Y, Cherng BPZ, Thien SY, Lee WHL, Kwa ALH, Chung SJ. Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic. Antibiotics 2022;11:846. [DOI: 10.3390/antibiotics11070846] [Reference Citation Analysis]
205 Notz Q, Herrmann J, Schlesinger T, Helmer P, Sudowe S, Sun Q, Hackler J, Roeder D, Lotz C, Meybohm P, Kranke P, Schomburg L, Stoppe C. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS. Nutrients 2021;13:2113. [DOI: 10.3390/nu13062113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Manavalan B, Basith S, Lee G. Comparative analysis of machine learning-based approaches for identifying therapeutic peptides targeting SARS-CoV-2. Brief Bioinform 2021:bbab412. [PMID: 34595489 DOI: 10.1093/bib/bbab412] [Reference Citation Analysis]
207 Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, Najafizadeh SR, Farhadi E, Jalili N, Esfahani M, Rahimi B, Kazemzadeh H, Mahmoodi Aliabadi M, Ghazanfari T, Sattarian M, Ebrahimi Louyeh H, Raeeskarami SR, Jamalimoghadamsiahkali S, Khajavirad N, Mahmoudi M, Rostamian A. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J 2020;56:2002808. [PMID: 32943404 DOI: 10.1183/13993003.02808-2020] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 35.0] [Reference Citation Analysis]
208 Sen A, Nigam A, Vachher M. Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10366-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Ansarin K, Tolouian R, Ardalan M, Taghizadieh A, Varshochi M, Teimouri S, Vaezi T, Valizadeh H, Saleh P, Safiri S, Chapman KR. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial. Bioimpacts 2020;10:209-15. [PMID: 32983936 DOI: 10.34172/bi.2020.27] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
210 Day JD, Park S, Ranard BL, Singh H, Chow CC, Vodovotz Y. Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model. Front Immunol 2021;12:754127. [PMID: 34777366 DOI: 10.3389/fimmu.2021.754127] [Reference Citation Analysis]
211 Kaur M, Tiwari S, Jain R. Protein based biomarkers for non-invasive Covid-19 detection. Sens Biosensing Res 2020;29:100362. [PMID: 32835001 DOI: 10.1016/j.sbsr.2020.100362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
212 Sertoglu E, Yucel C, Balık AR, Taşçı C, Bilge S, Ertuğrul MS, Nazaroğlu NK, Ozgurtas T. Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19. Nutrition 2022;96:111581. [DOI: 10.1016/j.nut.2021.111581] [Reference Citation Analysis]
213 Padda I, Khehra N, Jaferi U, Parmar MS. The Neurological Complexities and Prognosis of COVID-19. SN Compr Clin Med 2020;:1-12. [PMID: 33015552 DOI: 10.1007/s42399-020-00527-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
214 Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 - A systematic review. Life Sci. 2020;254:117788. [PMID: 32475810 DOI: 10.1016/j.lfs.2020.117788] [Cited by in Crossref: 191] [Cited by in F6Publishing: 179] [Article Influence: 95.5] [Reference Citation Analysis]
215 Ye J, Hua M, Zhu F. Machine Learning Algorithms are Superior to Conventional Regression Models in Predicting Risk Stratification of COVID-19 Patients. Risk Manag Healthc Policy 2021;14:3159-66. [PMID: 34349576 DOI: 10.2147/RMHP.S318265] [Reference Citation Analysis]
216 Root-Bernstein R. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Int J Mol Sci 2021;22:2108. [PMID: 33672738 DOI: 10.3390/ijms22042108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
217 Feigin E, Levinson T, Wasserman A, Shenhar-Tsarfaty S, Berliner S, Ziv-Baran T. Age-Dependent Biomarkers for Prediction of In-Hospital Mortality in COVID-19 Patients. J Clin Med 2022;11:2682. [PMID: 35628809 DOI: 10.3390/jcm11102682] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, Rezaie E, Ghaleh HEG, Aghamollaei H, Fasihi-Ramandi M, Hassanpour K, Alishiri G. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial. Arch Med Res 2021:S0188-4409(21)00141-7. [PMID: 34229896 DOI: 10.1016/j.arcmed.2021.06.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 20.0] [Reference Citation Analysis]
219 Giri A, Srinivasan A, Sundar IK. COVID-19: Sleep, Circadian Rhythms and Immunity - Repurposing Drugs and Chronotherapeutics for SARS-CoV-2. Front Neurosci 2021;15:674204. [PMID: 34220430 DOI: 10.3389/fnins.2021.674204] [Reference Citation Analysis]
220 Li D, Zhang Q, Tan Y, Feng X, Yue Y, Bai Y, Li J, Li J, Xu Y, Chen S, Xiao SY, Sun M, Li X, Zhu F. Prediction of COVID-19 Severity Using Chest Computed Tomography and Laboratory Measurements: Evaluation Using a Machine Learning Approach. JMIR Med Inform 2020;8:e21604. [PMID: 33038076 DOI: 10.2196/21604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
221 Gozar L, Șuteu CC, Gabor-Miklosi D, Cerghit-Paler A, Făgărășan A. Diagnostic Difficulties in a Case of Fetal Ventricular Tachycardia Associated with Neonatal COVID Infection: Case Report. Int J Environ Res Public Health 2021;18:12796. [PMID: 34886523 DOI: 10.3390/ijerph182312796] [Reference Citation Analysis]
222 Cao L, Zhang S, Wang E, Zhang Y, Bai Y, Luo X, Li Z, Li F, Tao L, Liu H. The CB index predicts prognosis of critically ill COVID-19 patients. Ann Transl Med 2020;8:1654. [PMID: 33490166 DOI: 10.21037/atm-20-7447] [Reference Citation Analysis]
223 Dolci A, Robbiano C, Aloisio E, Chibireva M, Serafini L, Falvella FS, Pasqualetti S, Panteghini M. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients. Clin Chem Lab Med 2020;59:433-40. [PMID: 33554505 DOI: 10.1515/cclm-2020-1361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Kazemi E, Soldoozi Nejat R, Ashkan F, Sheibani H. The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob 2021;20:17. [PMID: 33726761 DOI: 10.1186/s12941-021-00420-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Sullivan KD, Galbraith MD, Kinning KT, Bartsch K, Levinsky N, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter R, Jordan KR, Russell S, Dzieciatkowska M, Reisz JA, Gamboni F, Cendali F, Ghosh T, Monte AA, Bennett TD, Miller MG, Hsieh EWY, D'Alessandro A, Hansen KC, Espinosa JM. The COVIDome Explorer Researcher Portal. medRxiv 2021:2021. [PMID: 33758879 DOI: 10.1101/2021.03.04.21252945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Lipcsey M, Persson B, Eriksson O, Blom AM, Fromell K, Hultström M, Huber-Lang M, Ekdahl KN, Frithiof R, Nilsson B. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. Front Immunol 2021;12:627579. [PMID: 33692801 DOI: 10.3389/fimmu.2021.627579] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
227 Zhou W, Ye S, Wang W, Li S, Hu Q. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia. J Diabetes Res 2020;2020:3918723. [PMID: 33062712 DOI: 10.1155/2020/3918723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
228 Anai M, Akaike K, Iwagoe H, Akasaka T, Higuchi T, Miyazaki A, Naito D, Tajima Y, Takahashi H, Komatsu T, Masunaga A, Kishi H, Fujii K, Fukuda K, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respir Investig 2021;59:187-93. [PMID: 33281114 DOI: 10.1016/j.resinv.2020.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
229 Li Y, Ren H, Cao J. Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.109005] [Reference Citation Analysis]
230 Rais Y, Fu Z, Drabovich AP. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants. Clin Proteomics 2021;18:19. [PMID: 34384361 DOI: 10.1186/s12014-021-09325-x] [Reference Citation Analysis]
231 De la Cruz-cano E, Jiménez–gonzález CDC, Díaz-gandarilla JA, López–victorio CJ, Escobar-ramírez A, Uribe-lópez SA, Huerta-garcía E, Ayala-sumuano J, Morales-garcía V, Gútierrez-lópez L, González-garrido JA. Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study. F1000Res 2022;11:10. [DOI: 10.12688/f1000research.74023.1] [Reference Citation Analysis]
232 Fukao Y, Nagasawa H, Nihei Y, Hiki M, Naito T, Kihara M, Gohda T, Ueda S, Suzuki Y. COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. Clin Exp Nephrol 2021. [PMID: 34245398 DOI: 10.1007/s10157-021-02101-z] [Reference Citation Analysis]
233 Kaeuffer C, Ruch Y, Fabacher T, Hinschberger O, Mootien J, Eyriey M, Greigert V, Meyer N, Fafi-Kremer S, Lefebvre N, Hansmann Y, Martinot M, Danion F; COVID-19 Alsace Study Group . The BAS2IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019. Open Forum Infect Dis 2020;7:ofaa405. [PMID: 33274248 DOI: 10.1093/ofid/ofaa405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Janc J, Suchański M, Mierzchała-Pasierb M, Woźnica-Niesobska E, Łysenko L, Leśnik P. Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals. J Clin Med 2022;11:1769. [PMID: 35407377 DOI: 10.3390/jcm11071769] [Reference Citation Analysis]
235 Dell'Aquila P, Raimondo P, Orso D, De Luca P, Pozzessere P, Parisi CV, Bove T, Vetrugno L, Grasso S, Procacci V. A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study. Acta Biomed 2021;92:e2021233. [PMID: 34487072 DOI: 10.23750/abm.v92i4.11479] [Reference Citation Analysis]
236 Zhang X, Wang W, Wan C, Cheng G, Yin Y, Cao K, Zhang X, Wang Z, Miao S, Yu Y, Hu J, Huang R, Ge Y, Chen Y, Liu Y. A predictive model for respiratory distress in patients with COVID-19: a retrospective study. Ann Transl Med 2020;8:1585. [PMID: 33437784 DOI: 10.21037/atm-20-4977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
237 Li Z, Jiang N, Li X, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q. Two novel nomograms based on inflammatory cytokines or lymphocyte subsets to differentially diagnose severe or critical and Non-Severe COVID-19. Aging (Albany NY) 2021;13:17961-77. [PMID: 34282057 DOI: 10.18632/aging.203307] [Reference Citation Analysis]
238 Trecarichi EM, Mazzitelli M, Serapide F, Pelle MC, Tassone B, Arrighi E, Perri G, Fusco P, Scaglione V, Davoli C, Lionello R, La Gamba V, Marrazzo G, Busceti MT, Giudice A, Ricchio M, Cancelliere A, Lio E, Procopio G, Costanzo FS, Foti DP, Matera G, Torti C; IDTM UMG COVID-19 Group. Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility. Sci Rep 2020;10:20834. [PMID: 33257703 DOI: 10.1038/s41598-020-77641-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
239 Chen Q, Song Y, Wang L, Zhang Y, Han L, Liu J, Yang M, Ma J, Wang T. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study. Expert Rev Respir Med 2021;15:543-52. [PMID: 33249945 DOI: 10.1080/17476348.2021.1856659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
240 Campana P, Parisi V, Leosco D, Bencivenga D, Della Ragione F, Borriello A. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection. Cells 2020;9:E2046. [PMID: 32911691 DOI: 10.3390/cells9092046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
241 Li K, Li L, Wang X, Li H, Chen J, Liu L, Shao J, Xu Y, He L, Gong S, Xia H, Liang H. Comparative analysis of clinical features of SARS-CoV-2 and adenovirus infection among children. Virol J 2020;17:193. [PMID: 33302983 DOI: 10.1186/s12985-020-01461-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
242 Kudlinski B, Zgoła D, Stolińska M, Murkos M, Kania J, Nowak P, Noga A, Wojciech M, Zaborniak G, Zembron-lacny A. Systemic Inflammatory Predictors of In-Hospital Mortality in COVID-19 Patients: A Retrospective Study. Diagnostics 2022;12:859. [DOI: 10.3390/diagnostics12040859] [Reference Citation Analysis]
243 Zinellu A, Mangoni AA. Serum Prealbumin Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:638529. [PMID: 33575267 DOI: 10.3389/fmed.2021.638529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
244 Pérez-de-Llano L, Romay-Lema EM, Baloira-Villar A, Anchorena C, Torres-Durán ML, Sousa A, Corbacho-Abelaira D, Paz-Ferrin J, Diego-Roza C, Vilariño-Maneiro L, Marcos PJ, Montero-Martínez C, de la Iglesia-Martínez F, Riveiro-Blanco V, Rodríguez-Núñez N, Abal-Arca J, Bustillo-Casado M, Golpe R. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation. PLoS One 2021;16:e0253465. [PMID: 34161387 DOI: 10.1371/journal.pone.0253465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Al-Taie A, Arueyingho O, Khoshnaw J, Hafeez A. Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation. Arch Physiol Biochem 2022;:1-19. [PMID: 35704400 DOI: 10.1080/13813455.2022.2086265] [Reference Citation Analysis]
246 Kukoč A, Mihelčić A, Miko I, Romić A, Pražetina M, Tipura D, Drmić Ž, Čučković M, Ćurčić M, Blagaj V, Lasić H, Dolenc E, Hleb S, Almahariq H, Peršec J, Šribar A. Clinical and laboratory predictors at ICU admission affecting course of illness and mortality rates in a tertiary COVID-19 center. Heart & Lung 2022. [DOI: 10.1016/j.hrtlng.2022.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
247 Aviani JK, Halim D, Soeroto AY, Achmad TH, Djuwantono T. Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics. Rev Med Virol 2021. [PMID: 33621405 DOI: 10.1002/rmv.2225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
248 Alkharsah KR. Laboratory tests for the detection of SARS-CoV-2 infection: basic principles and examples. Ger Med Sci 2021;19:Doc06. [PMID: 34108851 DOI: 10.3205/000293] [Reference Citation Analysis]
249 Alay I, Yildiz S, Kaya C, Yasar KK, Aydin OA, Karaosmanoglu HK, Aydeniz B, Salihoglu O, Yaşar L, Ekin M. The clinical findings and outcomes of symptomatic pregnant women diagnosed with or suspected of having coronavirus disease 2019 in a tertiary pandemic hospital in Istanbul, Turkey. J Obstet Gynaecol Res 2020. [PMID: 32954601 DOI: 10.1111/jog.14493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
250 Hong W, Zhou X, Jin S, Lu Y, Pan J, Lin Q, Yang S, Xu T, Basharat Z, Zippi M, Fiorino S, Tsukanov V, Stock S, Grottesi A, Chen Q, Pan J. A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile. Front Cell Infect Microbiol 2022;12:819267. [DOI: 10.3389/fcimb.2022.819267] [Reference Citation Analysis]
251 Musikantow DR, Turagam MK, Sartori S, Chu E, Kawamura I, Shivamurthy P, Bokhari M, Oates C, Zhang C, Pumill C, Malick W, Hashemi H, Ruiz-Maya T, Hadley MB, Gandhi J, Sperling D, Whang W, Koruth JS, Langan MN, Sofi A, Gomes A, Harcum S, Cammack S, Ellsworth B, Dukkipati SR, Bassily-Marcus A, Kohli-Seth R, Goldman ME, Halperin JL, Fuster V, Reddy VY. Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes and Comparison to Influenza. JACC Clin Electrophysiol 2021:S2405-500X(21)00135-3. [PMID: 33895107 DOI: 10.1016/j.jacep.2021.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
252 Peng L, Lv QQ, Yang F, Wu XM, Zhang CC, Wang YQ, Huang WH, Li CW, Wei Y, Ma RQ, Tang KJ, Yao L, Li J, Wen WP. The interval between onset and admission predicts disease progression in COVID-19 patients. Ann Transl Med 2021;9:213. [PMID: 33708840 DOI: 10.21037/atm-20-5320] [Reference Citation Analysis]
253 Fröhlich E, Wahl R. Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients. Front Endocrinol (Lausanne) 2021;12:587518. [PMID: 33981284 DOI: 10.3389/fendo.2021.587518] [Reference Citation Analysis]
254 Rosa L, Tripepi G, Naldi E, Aimati M, Santangeli S, Venditto F, Caldarelli M, Valenti P. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study. J Clin Med 2021;10:4276. [PMID: 34575388 DOI: 10.3390/jcm10184276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Reference Citation Analysis]
256 ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Cámara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R. The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2020:S1658-3876(20)30122-9. [PMID: 32745466 DOI: 10.1016/j.hemonc.2020.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
257 Ponsford MJ, Burton RJ, Smith L, Khan PY, Andrews R, Cuff S, Tan L, Eberl M, Humphreys IR, Babolhavaeji F, Artemiou A, Pandey M, Jolles SRA, Underwood J. Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluation. J Clin Pathol 2021:jclinpath-2020-207157. [PMID: 33608408 DOI: 10.1136/jclinpath-2020-207157] [Reference Citation Analysis]
258 Birben B, Birben OD, Akın T, Akkurt G, Surel AA, Yakısık E, Erdem D. Efficacy of the delta neutrophil index in predicting 30-day mortality in COVID-19 patients requiring intensive care. Int J Clin Pract 2021;75:e13970. [PMID: 33368905 DOI: 10.1111/ijcp.13970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
259 Shi W, Peng X, Liu T, Cheng Z, Lu H, Yang S, Zhang J, Wang M, Gao Y, Shi Y, Zhang Z, Shan F. A deep learning-based quantitative computed tomography model for predicting the severity of COVID-19: a retrospective study of 196 patients. Ann Transl Med 2021;9:216. [PMID: 33708843 DOI: 10.21037/atm-20-2464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
260 Schrick D, Tőkés-Füzesi M, Réger B, Molnár T. Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19. Metabolites 2021;11:826. [PMID: 34940584 DOI: 10.3390/metabo11120826] [Reference Citation Analysis]
261 Wang L, Yang LM, Pei SF, Chong YZ, Guo Y, Gao XL, Tang QY, Li Y, Feng FM. CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients. Scand J Clin Lab Invest 2021;:1-8. [PMID: 34762008 DOI: 10.1080/00365513.2021.2000635] [Reference Citation Analysis]
262 Lakbar I, Luque-Paz D, Mege JL, Einav S, Leone M. COVID-19 gender susceptibility and outcomes: A systematic review. PLoS One 2020;15:e0241827. [PMID: 33141872 DOI: 10.1371/journal.pone.0241827] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
263 Kulaga SS, Miller CWT. Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19. Neurosci Biobehav Rev 2021;127:520-30. [PMID: 33992695 DOI: 10.1016/j.neubiorev.2021.05.008] [Reference Citation Analysis]
264 Ai Z, Zhou S, Li W, Wang M, Wang L, Hu G, Tao R, Wang X, Shen Y, Xie L, Ba Y, Wu H, Yang Y. "Fei Yan No. 1" as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study. Front Pharmacol 2020;11:581277. [PMID: 33132913 DOI: 10.3389/fphar.2020.581277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
265 Zhu Z, Yang Y, Fan L, Ye S, Lou K, Hua X, Huang Z, Shi Q, Gao G. Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study. J Clin Lab Anal 2021;35:e23911. [PMID: 34260764 DOI: 10.1002/jcla.23911] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
266 Malik SUF, Chowdhury PA, Hakim A, Islam MS, Alam MJ, Azad AK. Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study. Int J Environ Health Res 2021;:1-14. [PMID: 33504213 DOI: 10.1080/09603123.2021.1879741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
267 Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw 2020;31:44-9. [PMID: 32933891 DOI: 10.1684/ecn.2020.0448] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
268 Frankel AE, Reddy R, DeSuza KR, Deeb K, Carlin AF, Smith D, Xie Y, Naik E, Silver RT, Hasselbalch HC. Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clin Case Rep 2021;9:2228-35. [PMID: 33936671 DOI: 10.1002/ccr3.3997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
269 Lahmer T, Kriescher S, Herner A, Rothe K, Spinner CD, Schneider J, Mayer U, Neuenhahn M, Hoffmann D, Geisler F, Heim M, Schneider G, Schmid RM, Huber W, Rasch S. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study. PLoS One 2021;16:e0238825. [PMID: 33730058 DOI: 10.1371/journal.pone.0238825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
270 Skopljanac I, Pavicic Ivelja M, Budimir Mrsic D, Barcot O, Jelicic I, Domjanovic J, Dolic K. Can Lung Imaging Scores and Clinical Variables Predict Severe Course and Fatal Outcome in COVID-19 Pneumonia Patients? A Single-Center Observational Study. Life 2022;12:735. [DOI: 10.3390/life12050735] [Reference Citation Analysis]
271 Stringer D, Braude P, Myint PK, Evans L, Collins JT, Verduri A, Quinn TJ, Vilches-Moraga A, Stechman MJ, Pearce L, Moug S, McCarthy K, Hewitt J, Carter B; COPE Study Collaborators. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol 2021;50:420-9. [PMID: 33683344 DOI: 10.1093/ije/dyab012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
272 Luo Y, Xue Y, Mao L, Yuan X, Lin Q, Tang G, Song H, Wang F, Sun Z. Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019. Front Med (Lausanne) 2020;7:374. [PMID: 32671085 DOI: 10.3389/fmed.2020.00374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
273 Haitao T, Vermunt JV, Abeykoon J, Ghamrawi R, Gunaratne M, Jayachandran M, Narang K, Parashuram S, Suvakov S, Garovic VD. COVID-19 and Sex Differences: Mechanisms and Biomarkers. Mayo Clin Proc 2020;95:2189-203. [PMID: 33012349 DOI: 10.1016/j.mayocp.2020.07.024] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 23.5] [Reference Citation Analysis]
274 Sengupta S, Handoo A, Pande R, Kapoor RK. Retrospective Analysis of Clinical Laboratory Parameters, Therapeutics and Outcome in Patients Infected with SARS-CoV2. Indian J Clin Biochem 2021;:1-7. [PMID: 34785872 DOI: 10.1007/s12291-021-01009-5] [Reference Citation Analysis]
275 Sammartino D, Jafri F, Cook B, La L, Kim H, Cardasis J, Raff J. Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis. PLoS One 2021;16:e0251262. [PMID: 33970955 DOI: 10.1371/journal.pone.0251262] [Reference Citation Analysis]
276 Murri R, Masciocchi C, Lenkowicz J, Fantoni M, Damiani A, Marchetti A, Sergi PDA, Arcuri G, Cesario A, Patarnello S, Antonelli M, Bellantone R, Bernabei R, Boccia S, Calabresi P, Cambieri A, Cauda R, Colosimo C, Crea F, De Maria R, De Stefano V, Franceschi F, Gasbarrini A, Landolfi R, Parolini O, Richeldi L, Sanguinetti M, Urbani A, Zega M, Scambia G, Valentini V. A real-time integrated framework to support clinical decision making for covid-19 patients. Computer Methods and Programs in Biomedicine 2022;217:106655. [DOI: 10.1016/j.cmpb.2022.106655] [Reference Citation Analysis]
277 Ebrahimi N, Aslani S, Babaie F, Hemmatzadeh M, Hosseinzadeh R, Joneidi Z, Mehdizadeh Tourzani Z, Pakravan N, Mohammadi H. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics. Int Immunopharmacol 2020;89:107082. [PMID: 33068865 DOI: 10.1016/j.intimp.2020.107082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
278 Bayrak A, Duramaz A, Çakmur BB, Kural C, Basaran SH, Erçin E, Kural A, Ursavaş HT. The effect of COVID-19 positivity on inflammatory parameters and thirty day mortality rates in patients over sixty five years of age with surgically treated intertrochanteric fractures. Int Orthop 2021. [PMID: 34471936 DOI: 10.1007/s00264-021-05201-3] [Reference Citation Analysis]
279 Álvarez-Mon M, Ortega MA, Gasulla Ó, Fortuny-Profitós J, Mazaira-Font FA, Saurina P, Monserrat J, Plana MN, Troncoso D, Moreno JS, Muñoz B, Arranz A, Varona JF, Lopez-Escobar A, Barco AA. A Predictive Model and Risk Factors for Case Fatality of COVID-19. J Pers Med 2021;11:36. [PMID: 33430129 DOI: 10.3390/jpm11010036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
280 Goker Bagca B, Biray Avci C. The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19. Cytokine Growth Factor Rev 2020;54:51-62. [PMID: 32636055 DOI: 10.1016/j.cytogfr.2020.06.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
281 Li H, Lin H, Chen X, Li H, Li H, Lin S, Huang L, Chen G, Zheng G, Wang S, Hu X, Huang H, Tu H, Li X, Ji Y, Zhong W, Li Q, Fang J, Lin Q, Yu R, Xie B. Unvaccinated Children Are an Important Link in the Transmission of SARS-CoV-2 Delta Variant (B1.617.2): Comparative Clinical Evidence From a Recent Community Surge. Front Cell Infect Microbiol 2022;12:814782. [DOI: 10.3389/fcimb.2022.814782] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Chang Y, Bai M, You Q, Abdalla SS. Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/2755246] [Reference Citation Analysis]
283 Strohbehn GW, Reid PD, Ratain MJ. Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19. Clin Pharmacol Ther 2020;108:425-7. [PMID: 32488861 DOI: 10.1002/cpt.1931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
284 Li XL, Wu C, Xie JG, Zhang B, Kui X, Jia D, Liang CN, Zhou Q, Zhang Q, Gao Y, Zhou X, Hou G. Development and Validation of a Nomogram for Predicting the Disease Progression of Nonsevere Coronavirus Disease 2019. J Transl Int Med 2021;9:131-42. [PMID: 34497752 DOI: 10.2478/jtim-2021-0030] [Reference Citation Analysis]
285 Santa-cruz F, Araújo-júnior JGC, Siqueira LT, Leão LHA, Vianna C, Almeida ACA, Silva MS, Kreimer F, Ferraz ÁAB. Assessment of the clinical and laboratorial profile of patients with obesity and asymptomatic COVID-19 undergoing bariatric surgery in Brazil. OBES SURG. [DOI: 10.1007/s11695-022-05891-7] [Reference Citation Analysis]
286 Erdal GS, Polat O, Erdem GU, Korkusuz R, Hindilerden F, Yilmaz M, Yasar KK, Isiksacan N, Tural D. The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study. Int J Clin Oncol 2021;26:826-34. [PMID: 33486624 DOI: 10.1007/s10147-021-01863-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
287 Sun D, Chen X, Li H, Lu XX, Xiao H, Zhang FR, Liu ZS. SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China. World J Pediatr 2020;16:260-6. [PMID: 32504360 DOI: 10.1007/s12519-020-00368-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
288 Lesan V, Bewarder M, Metz C, Becker A, Mang S, Regitz E, Thurner L, Neumann F, Kos I, Christofyllakis K, Danziger G, Stilgenbauer S, Bals R, Lepper PM, Kaddu-Mulindwa D, Rixecker T. Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019. Intensive Care Med Exp 2021;9:45. [PMID: 34476598 DOI: 10.1186/s40635-021-00409-4] [Reference Citation Analysis]
289 Riva G, Castellano S, Nasillo V, Ottomano AM, Bergonzini G, Paolini A, Lusenti B, Milić J, De Biasi S, Gibellini L, Cossarizza A, Busani S, Girardis M, Guaraldi G, Mussini C, Manfredini R, Luppi M, Tagliafico E, Trenti T. Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients. Sci Rep 2021;11:12716. [PMID: 34135448 DOI: 10.1038/s41598-021-92236-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
290 Ye J, Zhang X, Zhu F, Tang Y. Application of a prediction model with laboratory indexes in the risk stratification of patients with COVID-19. Exp Ther Med 2021;21:182. [PMID: 33488791 DOI: 10.3892/etm.2021.9613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
291 Wang JM, Liu W, Chen X, McRae MP, McDevitt JT, Fenyö D. Predictive Modeling of Morbidity and Mortality in Patients Hospitalized With COVID-19 and its Clinical Implications: Algorithm Development and Interpretation. J Med Internet Res 2021;23:e29514. [PMID: 34081611 DOI: 10.2196/29514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Lingeswaran M, Goyal T, Ghosh R, Suri S, Mitra P, Misra S, Sharma P. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review. Indian J Clin Biochem 2020;35:260-73. [PMID: 32641873 DOI: 10.1007/s12291-020-00897-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
293 Hage R, Steinack C, Gautschi F, Pfister S, Inci I, Schuurmans MM. Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19. Transplantology 2021;2:229-45. [DOI: 10.3390/transplantology2020022] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
294 Du Y, Wang X, Qin Z, Zhang L. Clinical and diagnostic value of the combination of lymphocyte count and creatine kinase in the detection of coronavirus 2019. Exp Ther Med 2021;21:641. [PMID: 33968172 DOI: 10.3892/etm.2021.10073] [Reference Citation Analysis]
295 Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146:128-136.e4. [PMID: 32425269 DOI: 10.1016/j.jaci.2020.05.008] [Cited by in Crossref: 310] [Cited by in F6Publishing: 300] [Article Influence: 155.0] [Reference Citation Analysis]
296 Lipworth B, Chan R, Kuo CR. Predicting Severe Outcomes in COVID-19. J Allergy Clin Immunol Pract 2020;8:2582-4. [PMID: 32615256 DOI: 10.1016/j.jaip.2020.06.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
297 Hammad MO, Alseoudy MM. The sex-related discrepancy in laboratory parameters of severe COVID-19 patients with diabetes: A retrospective cohort study. Prim Care Diabetes 2021;15:713-8. [PMID: 34006475 DOI: 10.1016/j.pcd.2021.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Hakeam HA, Alsemari M, Duhailib ZA, Ghonem L, Alharbi SA, Almutairy E, Sheraim NMB, Alsalhi M, Alhijji A, AlQahtani S, Khalid M, Barry M. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study. J Cardiovasc Pharmacol Ther 2021;26:244-52. [PMID: 33231487 DOI: 10.1177/1074248420976279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
299 Kreidieh F, Temraz S. SARS-CoV-2 Infected Patient: from a Hematologist's Perspective. Mediterr J Hematol Infect Dis 2020;12:e2020078. [PMID: 33194152 DOI: 10.4084/MJHID.2020.078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
300 Potempa LA, Rajab IM, Hart PC, Bordon J, Fernandez-Botran R. Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections. Am J Trop Med Hyg 2020;103:561-3. [PMID: 32588812 DOI: 10.4269/ajtmh.20-0473] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
301 Tang F, Zhang X, Zhang B, Zhu B, Wang J. A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators. J Med Virol 2021. [PMID: 34403145 DOI: 10.1002/jmv.27275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
302 Li J, Huang Z, Lu S, Luo H, Tan Y, Ye P, Liu X, Wu Z, Wu C, Stalin A, Wang H, Liu Y, Shen L, Fan X, Zhang B, Yi J, Yao L, Xu Y, Wu J, Duan X. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking. Medicine (Baltimore) 2021;100:e27112. [PMID: 34941025 DOI: 10.1097/MD.0000000000027112] [Reference Citation Analysis]
303 Fierens J, De Bus L, Colpaert K, Boelens J, Gadeyne B, Decruyenaere J, Van Braeckel E, Depuydt P. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study. Acta Clin Belg 2021;:1-8. [PMID: 34709997 DOI: 10.1080/17843286.2021.1996068] [Reference Citation Analysis]
304 Prasetya IB, Cucunawangsih, Lorens JO, Sungono V, El-Khobar KE, Wijaya RS. Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia. Clin Epidemiol Glob Health 2021;11:100803. [PMID: 34124411 DOI: 10.1016/j.cegh.2021.100803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
305 Krejner-Bienias A, Grzela K, Grzela T. DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End? Arch Immunol Ther Exp (Warsz) 2021;69:1. [PMID: 33527308 DOI: 10.1007/s00005-020-00602-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Wang M, Fan Y, Chai Y, Cheng W, Wang K, Cao J, Hu X. Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China. Front Cell Infect Microbiol 2021;11:667487. [PMID: 34123873 DOI: 10.3389/fcimb.2021.667487] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Rola P, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, Gawryś J, Matys T, Szahidewicz-Krupska E, Gajecki D, Adamik B, Kaliszewski K, Kilis-Pstrusinska K, Letachowicz K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Majchrzak K, Sokołowski J, Jankowska EA, Madziarska K. Mortality Predictive Value of the C2HEST Score in Elderly Subjects with COVID-19-A Subanalysis of the COLOS Study. J Clin Med 2022;11:992. [PMID: 35207272 DOI: 10.3390/jcm11040992] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Vazzana N, Dipaola F, Ognibene S. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes. Acta Clin Belg 2022;77:268-72. [PMID: 32966166 DOI: 10.1080/17843286.2020.1824749] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
309 Burtscher B, Manco Urbina PA, Diacci C, Borghi S, Pinti M, Cossarizza A, Salvarani C, Berggren M, Biscarini F, Simon DT, Bortolotti CA. Sensing Inflammation Biomarkers with Electrolyte-Gated Organic Electronic Transistors. Adv Healthc Mater 2021;10:e2100955. [PMID: 34423579 DOI: 10.1002/adhm.202100955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 33832398 DOI: 10.1080/14787210.2021.1915129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
311 Smarz-Widelska I, Grywalska E, Morawska I, Forma A, Michalski A, Mertowski S, Hrynkiewicz R, Niedźwiedzka-Rystwej P, Korona-Glowniak I, Parczewski M, Załuska W. Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives. Int J Mol Sci 2021;22:7082. [PMID: 34209289 DOI: 10.3390/ijms22137082] [Reference Citation Analysis]
312 Liu XQ, Xue S, Xu JB, Ge H, Mao Q, Xu XH, Jiang HD. Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China. Acta Pharmacol Sin 2022;43:64-75. [PMID: 33742107 DOI: 10.1038/s41401-021-00627-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
313 Gutierrez L, Beckford J, Alachkar H. Deciphering the TCR Repertoire to Solve the COVID-19 Mystery. Trends Pharmacol Sci 2020;41:518-30. [PMID: 32576386 DOI: 10.1016/j.tips.2020.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
314 Zhang B, Yu Y, Hubert SM, Zhang Y, Lu J, Liu S, Xie F, Zhao L, Lei X, Deng W, Chen J, Li Y. Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study. Front Pharmacol 2020;11:576994. [PMID: 33192519 DOI: 10.3389/fphar.2020.576994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
315 Arcari L, Luciani M, Cacciotti L, Musumeci MB, Spuntarelli V, Pistella E, Martolini D, Manzo D, Pucci M, Marone C, Melandri S, Ansalone G, Santini C, Martelletti P, Volpe M, De Biase L. Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients. Intern Emerg Med 2020;15:1467-76. [DOI: 10.1007/s11739-020-02498-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
316 Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications. J Dtsch Dermatol Ges 2020;18:795-807. [PMID: 32761894 DOI: 10.1111/ddg.14169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
317 Venturini S, Orso D, Cugini F, Crapis M, Fossati S, Callegari A, Pellis T, Tomasello DC, Tonizzo M, Grembiale A, D'Andrea N, Vetrugno L, Bove T. Artificial neural network model from a case series of COVID-19 patients: a prognostic analysis. Acta Biomed 2021;92:e2021202. [PMID: 33988146 DOI: 10.23750/abm.v92i2.11086] [Reference Citation Analysis]
318 Maksimov VA, Torshin IY, Chuchalin AG, Tkacheva ON, Strazhesko ID, Gromova OA. The effectiveness and safety of a polypeptide drug (Laennec) for the treatment of COVID-19. jour 2020. [DOI: 10.31146/1682-8658-ecg-178-6-55-63] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
319 Ringel J, Ramlow A, Bock C, Sheriff A. Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase. Front Immunol 2021;12:708101. [PMID: 34408751 DOI: 10.3389/fimmu.2021.708101] [Reference Citation Analysis]
320 Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, Gabrilove JL, Sacks H. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med 2021;26:107-8. [PMID: 32934000 DOI: 10.1136/bmjebm-2020-111536] [Cited by in Crossref: 33] [Cited by in F6Publishing: 49] [Article Influence: 16.5] [Reference Citation Analysis]
321 El-Arif G, Khazaal S, Farhat A, Harb J, Annweiler C, Wu Y, Cao Z, Kovacic H, Abi Khattar Z, Fajloun Z, Sabatier JM. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. Molecules 2022;27:2048. [PMID: 35408447 DOI: 10.3390/molecules27072048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Che Mohd Nassir CMN, Hashim S, Wong KK, Abdul Halim S, Idris NS, Jayabalan N, Guo D, Mustapha M. COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease. Mol Neurobiol 2021;58:4188-215. [PMID: 34176095 DOI: 10.1007/s12035-021-02457-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
323 Spasov A, Kosolapov V, Babkov D, Klochkov V, Sokolova E, Miroshnikov M, Borisov A, Velikorodnaya Y, Smirnov A, Savateev K, Fedotov V, Kotovskaya S, Rusinov V. Discovery of Nitro-azolo[1,5-a]pyrimidines with Anti-Inflammatory and Protective Activity against LPS-Induced Acute Lung Injury. Pharmaceuticals 2022;15:537. [DOI: 10.3390/ph15050537] [Reference Citation Analysis]
324 Kaur S, Singh A, Kaur J, Verma N, Pandey AK, Das S, Bhattacharyya S, Guchhait P. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients. Blood Cells Mol Dis 2022;94:102653. [PMID: 35180460 DOI: 10.1016/j.bcmd.2022.102653] [Reference Citation Analysis]
325 Dramé M, Cofais C, Hentzien M, Proye E, Coulibaly PS, Demoustier-Tampère D, Destailleur MH, Lotin M, Cantagrit E, Cebille A, Desprez A, Blondiau F, Kanagaratnam L, Godaert L. Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review. Nutrients 2021;13:1339. [PMID: 33920639 DOI: 10.3390/nu13041339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
326 Sullivan KD, Galbraith MD, Kinning KT, Bartsch KW, Levinsky NC, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter RM, Jordan KR, Russell SA, Dzieciatkowska ME, Reisz JA, Gamboni F, Cendali FI, Ghosh T, Monte AA, Bennett TD, Miller MG, Hsieh EW, D'Alessandro A, Hansen KC, Espinosa JM. The COVIDome Explorer researcher portal. Cell Rep 2021;:109527. [PMID: 34348131 DOI: 10.1016/j.celrep.2021.109527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 [DOI: 10.1101/2020.05.08.20094755] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
328 Torrente-Rodríguez RM, Lukas H, Tu J, Min J, Yang Y, Xu C, Rossiter HB, Gao W. SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring. Matter 2020;3:1981-98. [PMID: 33043291 DOI: 10.1016/j.matt.2020.09.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 59] [Article Influence: 40.0] [Reference Citation Analysis]
329 da Silva-Neto PV, de Carvalho JCS, Pimentel VE, Pérez MM, Toro DM, Fraga-Silva TFC, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Neto NT, Souza COS, Fernandes TM, Bastos VAF, Degiovani AM, Constant LF, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, da Rocha JJR, Feres O, Frantz FG, Gerlach RF, Maruyama SR, Russo EMS, Viana AL, Fernandes APM, Santos IKFM, Bonato VLD, Boechat AL, Malheiro A, Sadikot RT, Dias-Baruffi M, Cardoso CRB, Faccioli LH, Sorgi CA, On Behalf Of The Imunocovid Study Group. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity. Viruses 2021;13:2521. [PMID: 34960790 DOI: 10.3390/v13122521] [Reference Citation Analysis]
330 Alkhafaji DM, Al Argan RJ, Albahrani S, Alwaheed AJ, Alqatari SG, Al Elq AH, Albaker W, Alwazzeh M, Alsulaiman AS, Alsulaiman RS, Almadan HM, Alhammad AA, Almajid AN, Hakami FH, Alanazi WK. The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease. IDR 2022;Volume 15:3477-89. [DOI: 10.2147/idr.s365179] [Reference Citation Analysis]
331 Ghosn M, Attallah N, Badr M, Abdallah K, De Oliveira B, Nadeem A, Varghese Y, Munde D, Salam S, Abduljawad B, Saleh K, Elkambergy H, Wahla A, Taha A, Dibu J, Bayrlee A, Hamed F, Rahman N, Mallat J. Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes. J Clin Med 2021;10:1217. [PMID: 33804100 DOI: 10.3390/jcm10061217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
332 Dheir H, Sipahi S, Yaylacı S, Çetin ES, Genç AB, Fırat N, Köroğlu M, Muratdağı G, Tomak Y, Özmen K, Ateş ÖF, Karabay O. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients. Turk J Med Sci 2021;51:428-34. [PMID: 33185367 DOI: 10.3906/sag-2007-260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
333 Mastroianni A, Greco S, Chidichimo L, Urso F, Greco F, Mauro MV, Vangeli V. Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis. Int J Immunopathol Pharmacol 2021;35:20587384211059675. [PMID: 34928722 DOI: 10.1177/20587384211059675] [Reference Citation Analysis]
334 Torun A, Çakırca TD, Çakırca G, Portakal RD. The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19. Rev Assoc Med Bras (1992) 2021;67:431-6. [PMID: 34468610 DOI: 10.1590/1806-9282.20200883] [Reference Citation Analysis]
335 Rodean IP, Biriș CI, Halațiu VB, Modiga A, Lazăr L, Benedek I, Benedek T. Is There a Link between COVID-19 Infection, Periodontal Disease and Acute Myocardial Infarction? Life (Basel) 2021;11:1050. [PMID: 34685421 DOI: 10.3390/life11101050] [Reference Citation Analysis]
336 Lau CS, Hoo SP, Koh JMJ, Phua SK, Aw TC. Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms. J Virol Methods 2021;296:114224. [PMID: 34214571 DOI: 10.1016/j.jviromet.2021.114224] [Reference Citation Analysis]
337 Almutairi AS, Abunurah H, Hadi Alanazi A, Alenazi F, Nagy H, Saad Almutairi N, Wells M, Alawam A, Alqahtani MM. The immunological response among COVID-19 patients with acute respiratory distress syndrome. J Infect Public Health 2021;14:954-9. [PMID: 34130119 DOI: 10.1016/j.jiph.2021.05.007] [Reference Citation Analysis]
338 Vaid A, Somani S, Russak AJ, De Freitas JK, Chaudhry FF, Paranjpe I, Johnson KW, Lee SJ, Miotto R, Richter F, Zhao S, Beckmann ND, Naik N, Kia A, Timsina P, Lala A, Paranjpe M, Golden E, Danieletto M, Singh M, Meyer D, O'Reilly PF, Huckins L, Kovatch P, Finkelstein J, Freeman RM, Argulian E, Kasarskis A, Percha B, Aberg JA, Bagiella E, Horowitz CR, Murphy B, Nestler EJ, Schadt EE, Cho JH, Cordon-Cardo C, Fuster V, Charney DS, Reich DL, Bottinger EP, Levin MA, Narula J, Fayad ZA, Just AC, Charney AW, Nadkarni GN, Glicksberg BS. Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation. J Med Internet Res 2020;22:e24018. [PMID: 33027032 DOI: 10.2196/24018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 22.0] [Reference Citation Analysis]
339 El-shabrawy M, Alsadik ME, El-shafei M, Abdelmoaty AA, Alazzouni AS, Esawy MM, Shabana MA. Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00054-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
340 Lampart M, Rüegg M, Jauslin AS, Simon NR, Zellweger N, Eken C, Tschudin-Sutter S, Bassetti S, Rentsch KM, Siegemund M, Bingisser R, Nickel CH, Osswald S, Kuster GM, Twerenbold R. Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls-A Prospective Cohort Study. J Clin Med 2021;10:2672. [PMID: 34204453 DOI: 10.3390/jcm10122672] [Reference Citation Analysis]
341 Hippchen T, Altamura S, Muckenthaler MU, Merle U. Hypoferremia is Associated With Increased Hospitalization and Oxygen Demand in COVID-19 Patients. Hemasphere 2020;4:e492. [PMID: 33205000 DOI: 10.1097/HS9.0000000000000492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
342 Mahgoub S, Kotb El-Sayed MI, El-Shehry MF, Mohamed Awad S, Mansour YE, Fatahala SS. Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19. Bioorg Chem 2021;116:105272. [PMID: 34474305 DOI: 10.1016/j.bioorg.2021.105272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
343 Karakoyun I, Colak A, Turken M, Altin Z, Arslan FD, Iyilikci V, Yilmaz N, Kose S. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol 2021;91:107285. [PMID: 33348293 DOI: 10.1016/j.intimp.2020.107285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
344 Avila-Nava A, Pech-Aguilar AG, Lugo R, Medina-Vera I, Guevara-Cruz M, Gutiérrez-Solis AL. Oxidative Stress Biomarkers and Their Association with Mortality among Patients Infected with SARS-CoV-2 in Mexico. Oxid Med Cell Longev 2022;2022:1058813. [PMID: 35746958 DOI: 10.1155/2022/1058813] [Reference Citation Analysis]
345 Theoharides TC. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. J Pers Med 2021;11:860. [PMID: 34575637 DOI: 10.3390/jpm11090860] [Reference Citation Analysis]
346 Kaman K, Azmy V, Chichra A, Britto-Leon C, Price C. Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support. Respir Med Case Rep 2021;33:101376. [PMID: 33680800 DOI: 10.1016/j.rmcr.2021.101376] [Reference Citation Analysis]
347 Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Reference Citation Analysis]
348 Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther 2022;13:122. [PMID: 35313959 DOI: 10.1186/s13287-022-02796-1] [Reference Citation Analysis]
349 Oksuz E, Malhan S, Gonen MS, Kutlubay Z, Keskindemirci Y, Jarrett J, Sahin T, Ozcagli G, Bilgic A, Bibilik MO, Tabak F. Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey. Adv Ther 2021;38:4935-48. [PMID: 34379304 DOI: 10.1007/s12325-021-01874-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
350 Linssen J, Ermens A, Berrevoets M, Seghezzi M, Previtali G, van der Sar-van der Brugge S, Russcher H, Verbon A, Gillis J, Riedl J, de Jongh E, Saker J, Münster M, Munnix IC, Dofferhof A, Scharnhorst V, Ammerlaan H, Deiteren K, Bakker SJ, Van Pelt LJ, Kluiters-de Hingh Y, Leers MP, van der Ven AJ. A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study. Elife 2020;9:e63195. [PMID: 33241996 DOI: 10.7554/eLife.63195] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
351 Falahi S, Zamanian MH, Feizollahi P, Rezaiemanesh A, Salari F, Mahmoudi Z, Gorgin Karaji A. Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population. Cytokine 2022;154:155889. [PMID: 35461173 DOI: 10.1016/j.cyto.2022.155889] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Duarte M, Pelorosso F, Nicolosi LN, Salgado MV, Vetulli H, Aquieri A, Azzato F, Castro M, Coyle J, Davolos I, Criado IF, Gregori R, Mastrodonato P, Rubio MC, Sarquis S, Wahlmann F, Rothlin RP. Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial. EClinicalMedicine 2021;37:100962. [PMID: 34189447 DOI: 10.1016/j.eclinm.2021.100962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
353 Vivian Thangaraj JW, Murhekar M, Mehta Y, Kataria S, Brijwal M, Gupta N, Choudhary A, Malhotra B, Vyas M, Sharma H, Yadav N, Bhatnagar T, Gupta N, Dar L, Gangakhedkar RR, Bhargava B. A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020. Indian J Med Res 2020;151:438-43. [PMID: 32474558 DOI: 10.4103/ijmr.IJMR_1722_20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
354 El-Arif G, Farhat A, Khazaal S, Annweiler C, Kovacic H, Wu Y, Cao Z, Fajloun Z, Khattar ZA, Sabatier JM. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19. Molecules 2021;26:6945. [PMID: 34834033 DOI: 10.3390/molecules26226945] [Reference Citation Analysis]
355 Kotru S, Klimuntowski M, Ridha H, Uddin Z, Askhar AA, Singh G, Howlader MMR. Electrochemical sensing: A prognostic tool in the fight against COVID-19. Trends Analyt Chem 2021;136:116198. [PMID: 33518850 DOI: 10.1016/j.trac.2021.116198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
356 Lim MX, Fong KK, Yeap TB. Use of extracorporeal blood purification therapy (ECBPT) as an adjuvant to high-dose corticosteroids in a severely ill COVID-19 patient with concomitant bacterial infection. BMJ Case Rep 2021;14:e245639. [PMID: 34645636 DOI: 10.1136/bcr-2021-245639] [Reference Citation Analysis]
357 Lobo CS, Rodrigues-Santos P, Pereira D, Núñez J, Trêpa JCD, Sousa DL, Lourenço JV, Coelho MF, de Almeida LP, da Cunha JS, Arnaut LG. Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation. Photochem Photobiol Sci 2022. [PMID: 35304729 DOI: 10.1007/s43630-022-00202-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
358 Sukrisman L, Sinto R. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital. J Int Med Res 2021;49:3000605211059939. [PMID: 34796762 DOI: 10.1177/03000605211059939] [Reference Citation Analysis]
359 Gorham J, Moreau A, Corazza F, Peluso L, Ponthieux F, Talamonti M, Izzi A, Nagant C, Ndieugnou Djangang N, Garufi A, Creteur J, Taccone FS. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis. PLoS One 2020;15:e0244628. [PMID: 33382773 DOI: 10.1371/journal.pone.0244628] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
360 Perpiñan C, Bertran L, Terra X, Aguilar C, Lopez-Dupla M, Alibalic A, Riesco D, Camaron J, Perrone F, Rull A, Reverté L, Yeregui E, Marti A, Vidal F, Auguet T. Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic Syndrome. J Pers Med 2021;11:227. [PMID: 33809913 DOI: 10.3390/jpm11030227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 De la Cruz-Cano E, Jiménez-González CDC, Díaz-Gandarilla JA, López-Victorio CJ, Escobar-Ramírez A, Uribe-López SA, Huerta-García E, Ayala-Sumuano JT, Morales-García V, Gútierrez-López L, González-Garrido JA. Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study. F1000Res 2022;11:10. [PMID: 35464048 DOI: 10.12688/f1000research.74023.2] [Reference Citation Analysis]
362 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
363 Ferrando SJ, Dornbush R, Lynch S, Shahar S, Klepacz L, Karmen CL, Chen D, Lobo SA, Lerman D. Neuropsychological, medical and psychiatric findings after recovery from acute COVID-19: A cross-sectional study. Journal of the Academy of Consultation-Liaison Psychiatry 2022. [DOI: 10.1016/j.jaclp.2022.01.003] [Reference Citation Analysis]
364 Bahadirli S, Kurt E. Predicting Intensive Care Unit Admissions for COVID-19 Patients in the Emergency Department. Disaster Med Public Health Prep 2021;:1-5. [PMID: 34462044 DOI: 10.1017/dmp.2021.283] [Reference Citation Analysis]
365 Timpau AS, Miftode RS, Petris AO, Costache II, Miftode IL, Rosu FM, Anton-Paduraru DT, Leca D, Miftode EG. Mortality Predictors in Severe COVID-19 Patients from an East European Tertiary Center: A Never-Ending Challenge for a No Happy Ending Pandemic. J Clin Med 2021;11:58. [PMID: 35011795 DOI: 10.3390/jcm11010058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
366 Brzezinski RY, Rabin N, Lewis N, Peled R, Kerpel A, Tsur AM, Gendelman O, Naftali-Shani N, Gringauz I, Amital H, Leibowitz A, Mayan H, Ben-Zvi I, Heller E, Shechtman L, Rogowski O, Shenhar-Tsarfaty S, Konen E, Marom EM, Ironi A, Rahav G, Zimmer Y, Grossman E, Ovadia-Blechman Z, Leor J, Hoffer O. Automated processing of thermal imaging to detect COVID-19. Sci Rep 2021;11:17489. [PMID: 34471180 DOI: 10.1038/s41598-021-96900-9] [Reference Citation Analysis]
367 Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K. COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen. J Dtsch Dermatol Ges 2020;18:795-809. [PMID: 32881300 DOI: 10.1111/ddg.14169_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
368 Vaira LA, De Vito A, Deiana G, Pes C, Giovanditto F, Fiore V, Lechien JR, Le Bon SD, Saussez S, Madeddu G, Babudieri S, Pazzola A, Bandiera F, Fois AG, Piana AF, Hopkins C, De Riu G. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol 2021. [PMID: 33983525 DOI: 10.1007/s00405-021-06868-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
369 Qin R, He L, Yang Z, Jia N, Chen R, Xie J, Fu W, Chen H, Lin X, Huang R, Luo T, Liu Y, Yao S, Jiang M, Li J. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis. Clin Rev Allergy Immunol 2022. [PMID: 35040086 DOI: 10.1007/s12016-021-08908-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
370 Eichhorn T, Linsberger I, Lauková L, Tripisciano C, Fendl B, Weiss R, König F, Valicek G, Miestinger G, Hörmann C, Weber V. Analysis of Inflammatory Mediator Profiles in Sepsis Patients Reveals That Extracellular Histones Are Strongly Elevated in Nonsurvivors. Mediators Inflamm 2021;2021:8395048. [PMID: 33790693 DOI: 10.1155/2021/8395048] [Reference Citation Analysis]
371 Poyraz BM, Engin ED, Engin AB, Engin A. The effect of environmental diesel exhaust pollution on SARS-CoV-2 infection: The mechanism of pulmonary ground glass opacity. Environ Toxicol Pharmacol 2021;86:103657. [PMID: 33838330 DOI: 10.1016/j.etap.2021.103657] [Reference Citation Analysis]
372 Schoergenhofer C, Jilma B, Stimpfl T, Karolyi M, Zoufaly A. Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19). Ann Intern Med 2020;173:670-2. [PMID: 32422065 DOI: 10.7326/M20-1550] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 17.5] [Reference Citation Analysis]
373 Yang Y, Cai Z, Zhang J. Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis. Biosci Rep 2021;41:BSR20203584. [PMID: 33480978 DOI: 10.1042/BSR20203584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
374 Ben Jemaa A, Salhi N, Ben Othmen M, Ben Ali H, Guissouma J, Ghadhoune H, Oueslati R, Dhaouadi H. Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19. Int Immunopharmacol 2022;109:108781. [PMID: 35461157 DOI: 10.1016/j.intimp.2022.108781] [Reference Citation Analysis]
375 Cai S, Chen Y, Zhao S, He D, Li Y, Xiong N, Li Z, Hu S. Dynamic 3D radiomics analysis using artificial intelligence to assess the stage of COVID-19 on CT images. Eur Radiol. [DOI: 10.1007/s00330-021-08533-1] [Reference Citation Analysis]
376 Lukas H, Xu C, Yu Y, Gao W. Emerging Telemedicine Tools for Remote COVID-19 Diagnosis, Monitoring, and Management. ACS Nano 2020;14:16180-93. [PMID: 33314910 DOI: 10.1021/acsnano.0c08494] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 24.5] [Reference Citation Analysis]
377 Martinez-fierro ML, González-fuentes C, Cid-guerrero D, González Delgado S, Carrillo-martínez S, Gutierrez-vela EF, Calzada-luévano JY, Rocha-pizaña MR, Martínez-rendón J, Castañeda-lópez ME, Garza-veloz I. Radiological Findings Increased the Successful of COVID-19 Diagnosis in Hospitalized Patients Suspected of Respiratory Viral Infection but with a Negative First SARS-CoV-2 RT-PCR Result. Diagnostics 2022;12:687. [DOI: 10.3390/diagnostics12030687] [Reference Citation Analysis]
378 Doglietto F, Vezzoli M, Gheza F, Lussardi GL, Domenicucci M, Vecchiarelli L, Zanin L, Saraceno G, Signorini L, Panciani PP, Castelli F, Maroldi R, Rasulo FA, Benvenuti MR, Portolani N, Bonardelli S, Milano G, Casiraghi A, Calza S, Fontanella MM. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg 2020;155:691-702. [PMID: 32530453 DOI: 10.1001/jamasurg.2020.2713] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 90.0] [Reference Citation Analysis]
379 Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, Cushing TR, Hopp L, Tiwari A, Hariri R, Sokolov R, Wheeler C, Kaushik A, Elsayegh A, Eliashiv D, Hedrick R, Jafari B, Johnson JP, Khorsandi M, Gonzalez N, Balakhani G, Lahiri S, Ghavidel K, Amaya M, Kloor H, Hussain N, Huang E, Cormier J, Wesson Ashford J, Wang JC, Yaghobian S, Khorrami P, Shamloo B, Moon C, Shadi P, Kateb B. COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications. J Alzheimers Dis 2020;77:459-504. [PMID: 32925078 DOI: 10.3233/JAD-200831] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 12.5] [Reference Citation Analysis]
380 Villoteau A, Asfar M, Otekpo M, Loison J, Gautier J, Annweiler C; GERIA-COVID study group. Elevated C-reactive protein in early COVID-19 predicts worse survival among hospitalized geriatric patients. PLoS One 2021;16:e0256931. [PMID: 34506514 DOI: 10.1371/journal.pone.0256931] [Reference Citation Analysis]
381 Wang W, Zhao Z, Liu X, Liu G, Xie D, Xu Z, Zhao J, Zhang J. Clinical features and potential risk factors for discerning the critical cases and predicting the outcome of patients with COVID-19. J Clin Lab Anal 2020;34:e23547. [PMID: 32860454 DOI: 10.1002/jcla.23547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
382 Vaira LA, De Vito A, Deiana G, Pes C, Giovanditto F, Fiore V, Lechien JR, Saussez S, Policicchio D, Boccaletti R, Madeddu G, Babudieri S, Pazzola A, Bandiera F, Fois AG, Piana AF, Hopkins C, De Riu G. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J Laryngol Otol 2021;135:723-8. [PMID: 34184623 DOI: 10.1017/S0022215121001651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
383 Rosa L, Vincenzo M, Annalisa C, Federica I, Giordano S, Giada P, Marco P, Irene M, Beatrice M, Elisa F, Matteo C, Alessandra B, Luca V, Flora P, Nicola M, Marina B, Ludovica FA. Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity. Intern Emerg Med 2022. [PMID: 35754075 DOI: 10.1007/s11739-022-03000-1] [Reference Citation Analysis]
384 Twe CW, Khoo DKY, Law KB, Ahmad Nordin NSB, Sathasivan S, Lim KC, Atikah SK, Syed Badaruddin SNAB, Chidambaram SK. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07362-x] [Reference Citation Analysis]
385 Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd. Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients. Mayo Clin Proc Innov Qual Outcomes 2021;5:388-402. [PMID: 33585800 DOI: 10.1016/j.mayocpiqo.2021.01.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
386 Pink I, Raupach D, Fuge J, Vonberg RP, Hoeper MM, Welte T, Rademacher J. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19. Infection 2021. [PMID: 34021897 DOI: 10.1007/s15010-021-01615-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Nascimento da Silva LC, Mendonça JSP, de Oliveira WF, Batista KLR, Zagmignan A, Viana IFT, Dos Santos Correia MT. Exploring lectin-glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses. Glycobiology 2021;31:358-71. [PMID: 33094324 DOI: 10.1093/glycob/cwaa099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
388 [DOI: 10.1101/2020.12.21.20248610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
389 Vetter P, Eberhardt CS, Meyer B, Martinez Murillo PA, Torriani G, Pigny F, Lemeille S, Cordey S, Laubscher F, Vu DL, Calame A, Schibler M, Jacquerioz F, Blanchard-Rohner G, Siegrist CA, Kaiser L, Didierlaurent AM, Eckerle I. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series. mSphere 2020;5:e00827-20. [PMID: 33177214 DOI: 10.1128/mSphere.00827-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
390 Vidal-Cevallos P, Higuera-De-La-Tijera F, Chávez-Tapia NC, Sanchez-Giron F, Cerda-Reyes E, Rosales-Salyano VH, Servin-Caamaño A, Vázquez-Medina MU, Méndez-Sánchez N. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Ann Hepatol 2021;24:100338. [PMID: 33647501 DOI: 10.1016/j.aohep.2021.100338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Karampoor S, Hesamizadeh K, Shams Z, Ghafari Novin A, Farahmand M, Zahednasab H, Mirzaei R, Zamani F, Hajibaba M, Bouzari B, Laali A, Tabibzadeh A, Hadi Karbalaie Niya M, Keyvani H. The role of lovastatin in the attenuation of COVID-19. Int Immunopharmacol 2021;101:108192. [PMID: 34607230 DOI: 10.1016/j.intimp.2021.108192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 Montrucchio G, Sales G, Rumbolo F, Palmesino F, Fanelli V, Urbino R, Filippini C, Mengozzi G, Brazzi L. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS One 2021;16:e0246771. [PMID: 33556140 DOI: 10.1371/journal.pone.0246771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
393 Nakakubo S, Suzuki M, Kamada K, Yamashita Y, Nakamura J, Horii H, Sato K, Matsumoto M, Abe Y, Tsuji K, Ishiguro N, Nasuhara Y, Konno S. Proposal of COVID-19 Clinical Risk Score for the management of suspected COVID-19 cases: a case control study. BMC Infect Dis 2020;20:858. [PMID: 33208116 DOI: 10.1186/s12879-020-05604-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
394 Romadhon PZ, Bintoro SUY, Suryantoro SD, Savitri M, Amrita PNA, Diansyah MN, Prayoga AA, Windradi C, Mahdi BA, Widiyastuti KN, Novendrianto D, Agustin ED, Alkaff FF, Prahasanti K, Dewanto DD. The improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients: a cross-sectional study from two second referral hospitals in Surabaya, Indonesia. F1000Res 2022;11:61. [DOI: 10.12688/f1000research.75135.1] [Reference Citation Analysis]
395 Yan H, Liang X, Du J, He Z, Wang Y, Lyu M, Yue L, Zhang F, Xue Z, Xu L, Ruan G, Li J, Zhu H, Xu J, Chen S, Zhang C, Lv D, Lin Z, Shen B, Zhu Y, Qian B, Chen H, Guo T. Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients. Proteomics 2021;21:e2100002. [PMID: 33987944 DOI: 10.1002/pmic.202100002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
396 Luo X MD, Jiaerken Y MD, Shen Z MD, Wang Q MD, Liu B PhD, Zhou H MD, Zheng H MD, Li Y MD, Gao Y MD, He S MD, Ji W MD, Liu Y MD, Ma J MD, Mao L MD, Wang X MD, Wang M MD, Su M MD, Huang P PhD, Shi L MD, Zhang M MD. Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging. Diabetes Obes Metab 2021;23:290-3. [PMID: 32945051 DOI: 10.1111/dom.14194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
397 Sayutina EV, Butorova LI, Tuaeva EM, Osadchuk MA, Shamuilova MM. Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic. Cardiovasc Ther Prev 2022;21:3195. [DOI: 10.15829/1728-8800-2022-3195] [Reference Citation Analysis]
398 Varnaitė R, García M, Glans H, Maleki KT, Sandberg JT, Tynell J, Christ W, Lagerqvist N, Asgeirsson H, Ljunggren HG, Ahlén G, Frelin L, Sällberg M, Blom K, Klingström J, Gredmark-Russ S. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients. J Immunol 2020;205:2437-46. [PMID: 32878912 DOI: 10.4049/jimmunol.2000717] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
399 Sakoulas G, Geriak M, Kullar R, Greenwood KL, Habib M, Vyas A, Ghafourian M, Dintyala VNK, Haddad F. Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019. Crit Care Explor 2020;2:e0280. [PMID: 33225306 DOI: 10.1097/CCE.0000000000000280] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]